Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,5.797194153970114e-46,29.909759115057128,3115.44657774489,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS4Y1', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.06671570745019e-43,0,0,73
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,9.40677438494943e-10,4.1549574787393695,86.35838473139358,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'NDUFB4', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'UQCR11', 'UQCR10', 'COX6A1', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",2.4880918248191247e-07,0,0,37
3,Glycolysis and Gluconeogenesis WP534,8.786875557053017e-06,5.5710044532409695,64.85903419301376,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A3', 'ENO1', 'ENO2', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH']",0.0015494190565603489,0,0,15
4,Oxidative phosphorylation WP623,2.877610726549392e-05,3.597990271377368,37.620460793923996,"['ATP5PF', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFB4', 'ATP6AP2', 'NDUFB2', 'NDUFC2', 'ATP5MC3', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS5', 'ATP5MF', 'ATP5ME']",0.003263127143753359,0,0,20
5,Nonalcoholic fatty liver disease WP4396,3.084241156666691e-05,2.3372493372493373,24.276120281815864,"['CEBPA', 'NDUFA13', 'COX7B', 'GSK3A', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX7A1', 'COX7C', 'UQCRH', 'BBC3', 'LEPR', 'UQCRFS1', 'CYC1', 'RAC1', 'XBP1', 'JUN', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'UQCRQ', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",0.003263127143753359,0,0,38
6,"GPCRs, Class A Rhodopsin-like WP455",6.007026190496683e-05,2.8478571935984736,27.6811595310797,"['GPR27', 'CHRM1', 'GPR87', 'GPR22', 'HTR2B', 'OPRL1', 'GPR83', 'ADRA1D', 'MCHR1', 'LTB4R', 'GPR171', 'P2RY12', 'GPR12', 'P2RY14', 'SSTR1', 'GPR6', 'ADRA2C', 'HTR5A', 'SSTR3', 'HCRTR2', 'MAS1', 'ADORA2A', 'LPAR6', 'FSHR', 'ACKR4']",0.005296194757954576,0,0,25
7,Mitochondrial CIV Assembly WP4922,0.00011294408364627602,4.329706561160567,39.35104767333346,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX6A1', 'HIGD1A', 'COX7C', 'COX6B1', 'TMEM177', 'SCO2', 'COX14']",0.008535345749840002,0,0,14
8,Proximal tubule transport WP4917,0.00024674344070608686,3.896043521266073,32.36506259707949,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'SLC47A1', 'ABCB1', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'CA4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.016315910016689993,0,0,14
9,Computational Model of Aerobic Glycolysis WP4629,0.00036226920278684496,9.720305569245934,77.01517631560655,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.021293378697137887,0,0,7
10,miR-517 relationship with ARCN1 and USP1 WP3596,0.0005461380016764344,inf,inf,"['CDKN1A', 'ID2', 'USP1', 'ARCN1']",0.02889070028868338,0,0,4
11,Mitochondrial complex III assembly WP4921,0.0006924380801478972,6.349394195548042,46.19369513756913,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.031351774298954416,0,0,8
12,Senescence and Autophagy in Cancer WP615,0.0007111933678401757,2.419021642343634,17.53443851162492,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'HMGA1', 'BMI1', 'GABARAP', 'RSL1D1', 'MAP1LC3B', 'MAP1LC3A', 'LAMP1', 'FKBP8', 'E2F1', 'SLC39A1', 'HRAS', 'SLC39A3']",0.031351774298954416,0,0,23
13,Myometrial relaxation and contraction pathways WP289,0.0011878546636107355,2.011413327147248,13.548088484514379,"['RGS14', 'YWHAB', 'ATP2A2', 'ETS2', 'ACTB', 'ACTG1', 'RGS4', 'GNG3', 'IGFBP6', 'NOS1', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'IGFBP3', 'IGFBP2', 'PRKCD', 'FOS', 'ACTA2', 'CREB3', 'CACNB3', 'ACTC1', 'PRKAR1A', 'PRKCQ', 'CALM3', 'ATF5', 'CALM1', 'CALM2']",0.0483365474653907,0,0,31
14,IL-18 signaling pathway WP4754,0.001557158721955051,1.7539160785376555,11.338878814848249,"['CEBPB', 'NRN1', 'CD83', 'STOML1', 'CD81', 'MEPCE', 'COX17', 'HSPB1', 'ENO1', 'ACACB', 'FUT1', 'CENPB', 'PTMS', 'IRAK1', 'TMSB4X', 'STMN1', 'TIMP3', 'RPS11', 'MAPK3', 'SLC12A3', 'JUN', 'USP5', 'IMP3', 'BAD', 'PRKCD', 'FN1', 'IL18', 'NDUFC1', 'FOS', 'BPGM', 'EEF2', 'ACTA2', 'NR4A1', 'ARL4D', 'UCK1', 'NACA', 'CYCS', 'BAX', 'NFKBIE', 'CDK5R2', 'ITM2C', 'ARF6', 'MYH7']",0.058838354565301565,0,0,43
15,Translation Factors WP107,0.0023494868111603776,2.6185206755969714,15.85136770801107,"['EIF4A2', 'EIF1AY', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF6', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3G', 'EIF3CL']",0.08285856820692265,0,0,16
16,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0025757721438619766,1.4738719017018571,8.786643466478235,"['RPL5', 'ARPC5L', 'HSPB1', 'NRARP', 'SHB', 'RPL10A', 'ELK1', 'RPL7', 'HERPUD1', 'ACTG1', 'RND1', 'TUBB8', 'RPL18A', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'CHAC1', 'RAC1', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'DUSP5', 'HSP90AA1', 'IGFBP3', 'PRKCD', 'RPS6', 'RPL13A', 'EPN1', 'RCN1', 'RAB37', 'KATNAL2', 'FSCN1', 'RPL27', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'SLC25A11', 'FJX1', 'ARF6', 'LRRC59', 'SET', 'NOTCH4', 'CRIP2', 'FOXO4', 'ACACB', 'FUT1', 'APOLD1', 'PPP2CA', 'STIP1', 'LDHA', 'PGK1', 'DNAJB9', 'CCT7', 'ABCF2', 'MAPK3', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'FN1', 'BMX', 'SOD2', 'RAB11A', 'DNAJA1', 'NR4A1', 'NR4A3', 'CYCS', 'HYOU1', 'CALR', 'EIF4G2', 'HSPA1A']",0.0851614665064366,0,0,76
17,Glycolysis in senescence WP5049,0.0029323105008490107,6.661477832512316,38.84950290200372,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.09124660323230156,0,0,6
18,Selenium Micronutrient Network WP15,0.004099106183053563,2.5282263505915163,13.897625696365642,"['GPX4', 'HBA1', 'KMO', 'SELENOK', 'SOD2', 'SELENOH', 'SOD1', 'PRDX3', 'SELENOM', 'PRDX5', 'RFK', 'SELENOW', 'PNPO', 'SEPHS2', 'MSRB1']",0.12046817615751859,0,0,15
19,Pre-implantation embryo WP3527,0.004796496522103766,3.571076185777715,19.069080873736137,"['EGR1', 'BATF3', 'ARGFX', 'DDIT3', 'AQP9', 'HMGA1', 'FOSB', 'ATP1A1', 'HNRNPAB']",0.1335445610627838,0,0,9
20,Vitamin D Receptor Pathway WP2877,0.005533163889299475,2.1003668763102725,10.915597194393776,"['CDKN2D', 'CEBPA', 'CDKN1A', 'ABCB1', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'CYP3A5', 'CEACAM1', 'BGLAP', 'NINJ1', 'CREG2', 'S100A6', 'TIMP2', 'TIMP3', 'SOSTDC1', 'PRKCQ', 'CLPTM1L']",0.1463521848719711,0,0,20
21,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0062620107207266105,2.3833321552272566,12.091249256488407,"['NDUFA13', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'TMEM70', 'NDUFS5', 'NDUFAF4']",0.15774303196497033,0,0,15
22,Cori Cycle WP1946,0.008273455786851222,4.757353976073188,22.810099319266133,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.19893900505655895,0,0,6
23,Apoptosis Modulation and Signaling WP1772,0.00866241397765022,2.0861000991080276,9.906392555381043,"['JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'BNIP3', 'FOS', 'BBC3', 'CAPNS1', 'IRAK1', 'CASP6', 'TOLLIP', 'PEA15', 'CYCS', 'BAX', 'BCL2L2', 'MAPK3', 'HSPA1A']",0.19923552148595505,0,0,18
24,Transcriptional cascade regulating adipogenesis WP4211,0.010710477785609728,5.54849827671098,25.170944336205988,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG']",0.23600545126519284,0,0,5
25,Metabolic reprogramming in colon cancer WP4290,0.011153376713855995,2.4696969696969697,11.103789638924654,"['ACLY', 'LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'PYCR2', 'PDHB', 'ENO1', 'ALDOB', 'SLC16A3', 'GAPDH']",0.23600545126519284,0,0,12
26,Nucleotide GPCRs WP80,0.012660783060940728,16.635022134776193,72.6825041056678,"['ADORA2A', 'LPAR6', 'LTB4R']",0.2539508979977779,0,0,3
27,HIF1A and PPARG regulation of glycolysis WP2456,0.012961577024461256,7.395669291338582,32.13984749883943,"['LDHA', 'TPI1', 'PPARG', 'GAPDH']",0.2539508979977779,0,0,4
28,Exercise-induced Circadian Regulation WP410,0.01467623903352646,2.257569204152249,9.530385930035232,"['DAZAP2', 'HSPA8', 'CEBPB', 'BTG1', 'GSTP1', 'NCOA4', 'GFRA1', 'HERPUD1', 'PER2', 'DNAJA1', 'STBD1', 'SUMO3', 'EIF4G2']",0.27727608745483917,0,0,13
29,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.015323384910286031,2.1613913616880978,9.031104045725696,"['FZD1', 'CDKN1A', 'JUN', 'CDKN1B', 'FN1', 'ELK1', 'SOD1', 'PPP2CA', 'TMSB4X', 'NEFL', 'NEFM', 'NOS1', 'NEFH', 'PFN2']",0.27951967646694176,0,0,14
30,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.01693041267299607,2.96094674556213,12.076646813164704,"['RAB3B', 'EGR2', 'RAB3A', 'HSPB1', 'NEFL', 'MFN2', 'RABAC1', 'RAB11A']",0.2889093001295136,0,0,8
31,Sleep regulation WP3591,0.01693041267299607,2.96094674556213,12.076646813164704,"['CHRNB2', 'AHCY', 'STAR', 'ADORA2A', 'IL18', 'GHRL', 'FOS', 'HCRTR2']",0.2889093001295136,0,0,8
32,Kynurenine Pathway and links to Cellular Senescence WP5044,0.018370314365858464,3.6995073891625614,14.787002312517568,"['CDKN1A', 'TDO2', 'HAAO', 'NOS1', 'KMO', 'ACMSD']",0.30368425936059773,0,0,6
33,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.02173570361453421,1.9333620318553595,7.402454696655972,"['HSPA8', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'TUBA4A', 'PSMD8', 'TUBB8', 'PSMC5', 'TUBA1A', 'TUBB2A', 'PSMD2', 'PSMD3', 'STUB1', 'HSPA1B', 'HSPA1A']",0.3434046876259141,0,0,16
34,Photodynamic therapy-induced unfolded protein response WP3613,0.022071378788811113,2.7756410256410255,10.584833738901034,"['NARS', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1', 'BBC3']",0.3434046876259141,0,0,8
35,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.02582248417158312,3.9625096715200114,14.488954998956647,"['CD63', 'CD81', 'HSPB1', 'ETS2', 'SOD1']",0.37944705907687415,0,0,5
36,Galanin receptor pathway WP4970,0.02582248417158312,3.9625096715200114,14.488954998956647,"['CDKN1A', 'CDKN1B', 'PRKCD', 'PPARG', 'FOS']",0.37944705907687415,0,0,5
37,G1 to S cell cycle control WP45,0.029417781018027868,2.006014170374032,7.073518884738129,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'CDKN2A', 'CCNA1', 'CREB3', 'CCNE2', 'TFDP2', 'RPA3', 'MCM3', 'E2F1', 'MCM4']",0.41641170706125447,0,0,13
38,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.03098537377097825,2.379237437451547,8.266041873919775,"['PRKCH', 'STAR', 'FSHR', 'PRKCD', 'PRKCQ', 'AMH', 'HRAS', 'PLCB2', 'MAPK3']",0.41641170706125447,0,0,9
39,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.03098537377097825,2.379237437451547,8.266041873919775,"['LDHA', 'ANGPT2', 'PKM', 'IGFBP3', 'BNIP3', 'IGFBP2', 'PGK1', 'BAX', 'SLC2A3']",0.41641170706125447,0,0,9
40,Spinal Cord Injury WP2431,0.03148670752826121,1.755307495696625,6.070186487031067,"['RTN4R', 'EGR1', 'CDKN1B', 'MIF', 'FOS', 'RTN4', 'LTB4R', 'RHOB', 'SELP', 'FKBP1A', 'NR4A1', 'ACAN', 'APEX1', 'E2F1', 'NOS1', 'RAC1', 'ROS1', 'MAPK3']",0.41641170706125447,0,0,18
41,Melanoma WP4685,0.033690230899294064,1.8520534388916379,6.279474912522601,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'MITF', 'FOS', 'ELK1', 'E2F1', 'BAX', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.43468614989576976,0,0,15
42,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.03465991136698659,3.026332288401254,10.175048326693197,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3G', 'EIF3CL', 'EIF1']",0.43654983602704533,0,0,6
43,Gastrin signaling pathway WP4659,0.04608022948986228,1.611024844720497,4.9577215923083635,"['CHGA', 'EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'JAG1', 'CDKN1B', 'CDKN2A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'ELK1', 'RHOB', 'PRKCQ', 'PPARG', 'RAC1', 'HRAS', 'MEF2D', 'MAPK3']",0.5668939860497011,0,0,20
44,Cellular Proteostasis WP4918,0.04979493036948055,5.544023610427939,16.631195429640325,"['VBP1', 'PFDN5', 'PFDN6']",0.5853670703434491,0,0,3
45,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.04979493036948055,5.544023610427939,16.631195429640325,"['HSD11B1', 'HSD11B2', 'STAR']",0.5853670703434491,0,0,3
46,Calcium Regulation in the Cardiac Cell WP536,0.05319237158303465,1.4946022681702251,4.384924343233023,"['GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'ATP2A2', 'ADRA1D', 'RGS4', 'GNG3', 'PLN', 'YWHAG', 'YWHAH', 'PRKCH', 'PRKCD', 'ATP1B1', 'GJD2', 'FKBP1A', 'SLC8A3', 'CACNB3', 'PRKAR1A', 'PRKCQ', 'CALM3', 'CALR', 'CASQ1', 'CALM1', 'CALM2']",0.6038882768662484,0,0,25
47,Nuclear Receptors Meta-Pathway WP2882,0.05383178563165177,1.3733213733213734,4.012695601527367,"['ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'GSTP1', 'AMIGO2', 'KEAP1', 'SLC2A3', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'DNAJB1', 'FTH1', 'ENC1', 'CYP1B1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'GSTM4', 'EGR1', 'JUN', 'HSP90AA1', 'JUND', 'GADD45B', 'SLC10A1', 'PLK2', 'TSC22D3', 'AIP', 'NRG1', 'SLC2A9', 'PSMC5', 'B3GNT5', 'BHLHE40', 'BAX', 'SPRY1', 'HSPA1A', 'FKBP5', 'FTL']",0.6038882768662484,0,0,38
48,Ferroptosis WP4313,0.05479515555686185,2.081277750370005,6.04435004485839,"['PRNP', 'MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'PCBP1', 'NCOA4', 'ACSL5', 'FTL']",0.6038882768662484,0,0,9
49,Circadian rhythm related genes WP3594,0.056989167209201344,1.42610629649513,4.085643483670646,"['MAGEL2', 'AHCY', 'CHRM1', 'SUV39H1', 'CIPC', 'BHLHE41', 'OPRL1', 'PPP1CC', 'DBP', 'UBC', 'RPS27A', 'SKP1', 'CHRNB2', 'KLF10', 'EGR1', 'JUN', 'EGR3', 'JUND', 'CARTPT', 'HCRTR2', 'NR2F6', 'PER2', 'STAR', 'ADORA2A', 'ID2', 'BHLHE40', 'PPARG', 'GHRL', 'ATF5', 'UBA52']",0.6152503970136227,0,0,30
50,Aryl Hydrocarbon Receptor Pathway WP2873,0.062341903610951106,2.2844925057257996,6.339744198779168,"['HSP90AA1', 'JUN', 'CDKN1B', 'JUND', 'AIP', 'CYP1B1', 'BAX']",0.6410887454979323,0,0,7
51,Peptide GPCRs WP24,0.062341903610951106,2.2844925057257996,6.339744198779168,"['FSHR', 'GNRHR', 'OPRL1', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2']",0.6410887454979323,0,0,7
52,Effects of nitric oxide WP1995,0.06301817536085534,11.08456243854474,30.64141172349374,"['HBA1', 'NOS1']",0.6410887454979323,0,0,2
53,Hypertrophy Model WP516,0.07367511146494908,3.168447694038245,8.263597498634486,"['JUND', 'NR4A3', 'WDR1', 'IL18']",0.7061235914131014,0,0,4
54,Tryptophan metabolism WP465,0.0756110097414757,2.1573845901100706,5.570697900307569,"['TDO2', 'HAAO', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.7061235914131014,0,0,7
55,Complement system WP2806,0.07589878821402396,1.9208379188645592,4.952601207639431,"['SELP', 'PRNP', 'FKBP2', 'GNA15', 'RPS19', 'F12', 'SERPING1', 'CD59', 'CALR']",0.7061235914131014,0,0,9
56,"GPCRs, Other WP117",0.07589878821402396,1.9208379188645592,4.952601207639431,"['GPR162', 'ADORA2A', 'FSHR', 'GPR88', 'GNRHR', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2']",0.7061235914131014,0,0,9
57,CAMKK2  Pathway WP4874,0.0764096707777052,2.0175721714183252,5.18848142443493,"['FIS1', 'MAP1LC3A', 'WFS1', 'NOS1', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.7061235914131014,0,0,8
58,NAD Biosynthesis II (from tryptophan) WP2485,0.07741997788650261,4.157648794884407,10.637387762179417,"['TDO2', 'HAAO', 'KMO']",0.7061235914131014,0,0,3
59,Pregnane X receptor pathway WP2876,0.08453008090094297,2.520701848619131,6.22776652961583,"['HSP90AA1', 'PSMC5', 'ABCB1', 'CYP3A5', 'CYP3A7']",0.7579053016372683,0,0,5
60,Breast cancer pathway WP4262,0.08674560421075433,1.4379227758630762,3.5153984212928315,"['SHC4', 'FZD1', 'JUN', 'CDKN1A', 'GADD45B', 'NOTCH4', 'WNT7A', 'FOS', 'FGF1', 'DLL3', 'FRAT1', 'FGF7', 'FRAT2', 'HEY1', 'CSNK2B', 'E2F1', 'BAX', 'WNT2', 'HRAS', 'SKP1', 'FGF10', 'MAPK3']",0.7648070771248173,0,0,22
61,Folate Metabolism WP176,0.09040382215063138,2.043656455085471,4.911864388851015,"['AHCY', 'GPX4', 'RFK', 'NOS1', 'HBA1', 'SOD2', 'SOD1']",0.783993801929246,0,0,7
62,miRNAs involved in DNA damage response WP1545,0.09760144267173432,2.7721456692913384,6.450403200126287,"['CDKN1A', 'CDKN1B', 'H2AFX', 'E2F1']",0.8320416453050767,0,0,4
63,NRF2 pathway WP2884,0.09909002581137964,1.4699177986358072,3.398047913856772,"['GSTM4', 'EGR1', 'HSP90AA1', 'HSP90AB1', 'SRXN1', 'GSTP1', 'KEAP1', 'SLC2A3', 'NRG1', 'SLC5A3', 'SLC2A9', 'DNAJB1', 'FTH1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'FTL', 'HSPA1A']",0.8320416453050767,0,0,18
64,Purinergic signaling WP4900,0.10530933022532071,2.310438207779419,5.200457366554141,"['P2RY12', 'GNAZ', 'ADORA2A', 'LPAR6', 'P2RY14']",0.8623182974009713,0,0,5
65,Genotoxicity pathway WP4286,0.10595593446325735,1.6497430764097432,3.7032310488564604,"['ACTA2', 'PLK3', 'CDKN1A', 'RPS27', 'EI24', 'ID2', 'PCDH8', 'B3GNT2', 'TRIAP1', 'TRIM22', 'PHLDA3']",0.8623182974009713,0,0,11
66,IL1 and megakaryocytes in obesity WP2865,0.11018463586444191,3.325823905558288,7.335429930696996,"['IRAK1', 'IL18', 'TIMP2']",0.8676667620466996,0,0,3
67,Trans-sulfuration pathway WP2333,0.11018463586444191,3.325823905558288,7.335429930696996,"['AHCY', 'GOT1', 'MAT2B']",0.8676667620466996,0,0,3
68,Cells and molecules involved in local acute inflammatory response  WP4493,0.11337562009033257,5.541789577187807,12.064746909627978,"['SELP', 'ITGA4']",0.8676667620466996,0,0,2
69,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.11337562009033257,5.541789577187807,12.064746909627978,"['ATP4A', 'CHRM1']",0.8676667620466996,0,0,2
70,Aryl Hydrocarbon Receptor Netpath WP2586,0.1157030222073508,1.7216712314784888,3.7131774539789095,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'PSRC1', 'E2F1', 'AIP', 'LPL', 'CYP1B1', 'HRAS']",0.8676667620466996,0,0,9
71,Pathways in clear cell renal cell carcinoma WP4018,0.11688319534737411,1.4867993214108999,3.1915339448862556,"['TPI1', 'BHLHE41', 'ENO1', 'ENO2', 'ACACB', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'KCNJ2', 'BAP1']",0.8676667620466996,0,0,15
72,Amyotrophic lateral sclerosis (ALS) WP2447,0.12033606184938024,1.7749901380670612,3.7584829271764577,"['BAD', 'NEFL', 'BAX', 'NEFM', 'NOS1', 'RAC1', 'NEFH', 'SOD1']",0.8676667620466996,0,0,8
73,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.12446542738288977,1.3718814771566195,2.8586268771850882,"['CHRNB2', 'EGR1', 'JUN', 'CEBPB', 'TSPYL1', 'CAV3', 'YWHAB', 'SSTR1', 'HSP90B1', 'NEUROD1', 'ADCYAP1', 'AR', 'PRKAR1A', 'BHLHE40', 'PKNOX1', 'SCN3B', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAG', 'YWHAH']",0.8676667620466996,0,0,21
74,TP53 network WP1742,0.1246284788660131,2.463910761154856,5.1308924555434166,"['CDKN1A', 'CDKN2A', 'BAX', 'BBC3']",0.8676667620466996,0,0,4
75,Glucocorticoid Receptor Pathway WP2880,0.12483033307579233,1.6317287033273329,3.395300758048982,"['HSP90AA1', 'JUN', 'GADD45B', 'TSC22D3', 'B3GNT5', 'PLK2', 'ENC1', 'AMIGO2', 'BHLHE40', 'SPRY1']",0.8676667620466996,0,0,10
76,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.1283305362157667,2.132522819376586,4.378380759040082,"['H3F3B', 'H2AFZ', 'H2AFX', 'DUSP6', 'MAPK3']",0.8676667620466996,0,0,5
77,Ovarian infertility WP34,0.1283305362157667,2.132522819376586,4.378380759040082,"['EGR1', 'CEBPB', 'CDKN1B', 'SMPD1', 'FSHR']",0.8676667620466996,0,0,5
78,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.1283305362157667,2.132522819376586,4.378380759040082,"['JUN', 'SRXN1', 'GSTP1', 'KEAP1', 'FOS']",0.8676667620466996,0,0,5
79,Cell cycle WP179,0.1295759436704901,1.3879524045612295,2.836264266668178,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'GADD45B', 'YWHAB', 'CDKN2A', 'ANAPC11', 'MAD2L2', 'CCNA1', 'PTTG1', 'CCNE2', 'TFDP2', 'MCM3', 'E2F1', 'MCM4', 'YWHAG', 'SKP1', 'YWHAH']",0.8676667620466996,0,0,19
80,Androgen receptor signaling pathway WP138,0.14274436552604494,1.4095238095238096,2.7439198620723033,"['CDKN1A', 'JUN', 'NCOA4', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'RHOB', 'AR', 'BAG1', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN', 'RAD9A']",0.8688791602600568,0,0,16
81,Vitamin A and carotenoid metabolism WP716,0.14358431167050792,1.764505578206909,3.4246104405540754,"['CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'ALDH1A1', 'LPL', 'BCO1']",0.8688791602600568,0,0,7
82,Matrix Metalloproteinases WP129,0.1471941149556927,2.7712739793408754,5.309769406244888,"['MMP15', 'TIMP2', 'TIMP3']",0.8688791602600568,0,0,3
83,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.1471941149556927,2.7712739793408754,5.309769406244888,"['JUN', 'PRKCQ', 'MAPK3']",0.8688791602600568,0,0,3
84,Alzheimer's disease WP2059,0.147905146669927,1.4386196285306077,2.7494669766284274,"['PSENEN', 'ATP5MD', 'BAD', 'ATP2A2', 'LPL', 'CYCS', 'CALM3', 'NOS1', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.8688791602600568,0,0,14
85,Cell migration and invasion through p75NTR WP4561,0.1491860104018075,1.8482758620689654,3.5164582371860433,"['EFNA1', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'RAC1']",0.8688791602600568,0,0,6
86,Canonical and non-canonical Notch signaling WP3845,0.1534065944637314,1.9800239150313006,3.7118783691711887,"['JAG1', 'MAML2', 'HEY1', 'NOTCH4', 'DLL3']",0.8688791602600568,0,0,5
87,Gastric Cancer Network 1 WP2361,0.1534065944637314,1.9800239150313006,3.7118783691711887,"['CCNA1', 'ACTL6A', 'MCM4', 'GATD3B', 'GATD3A']",0.8688791602600568,0,0,5
88,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.1534065944637314,1.9800239150313006,3.7118783691711887,"['LDHA', 'RPS6', 'KEAP1', 'PDHB', 'ACACB']",0.8688791602600568,0,0,5
89,Monoamine GPCRs WP58,0.1534065944637314,1.9800239150313006,3.7118783691711887,"['CHRM1', 'HTR2B', 'ADRA1D', 'HTR5A', 'ADRA2C']",0.8688791602600568,0,0,5
90,Striated Muscle Contraction Pathway WP383,0.1534065944637314,1.9800239150313006,3.7118783691711887,"['ACTA2', 'MYOM1', 'MYBPC1', 'ACTC1', 'ACTG1']",0.8688791602600568,0,0,5
91,Differentiation of white and brown adipocyte WP2895,0.15439440654904601,2.2173228346456693,4.142502008879952,"['CEBPA', 'CEBPB', 'EBF3', 'PPARG']",0.8688791602600568,0,0,4
92,Imatinib and Chronic Myeloid Leukemia WP3640,0.15439440654904601,2.2173228346456693,4.142502008879952,"['SPRED2', 'ABCB1', 'CDKN1B', 'PIM2']",0.8688791602600568,0,0,4
93,MAPK pathway in congenital thyroid cancer WP4928,0.15439440654904601,2.2173228346456693,4.142502008879952,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.8688791602600568,0,0,4
94,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.15439440654904601,2.2173228346456693,4.142502008879952,"['GSK3A', 'BAX', 'BCL2L14', 'BCL2L2']",0.8688791602600568,0,0,4
95,Base Excision Repair WP4752,0.16402877202779453,1.6876379454432469,3.0507657744860355,"['POLE4', 'FEN1', 'NEIL2', 'APEX1', 'POLD2', 'POLE3', 'APEX2']",0.9086533020261036,0,0,7
96,Pathogenic Escherichia coli infection WP2272,0.16489738562288458,1.5598482979773063,2.8115203374571602,"['TUBB8', 'TUBA1A', 'TUBB2A', 'TUBB', 'ARPC5L', 'TUBB4B', 'ACTB', 'TUBA4A', 'ACTG1']",0.9086533020261036,0,0,9
97,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.17025516208361471,3.6941986234021633,6.540419863185862,"['PPARG', 'CYP2C18']",0.9190304157370631,0,0,2
98,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.17025516208361471,3.6941986234021633,6.540419863185862,"['CDKN1A', 'ABCB1']",0.9190304157370631,0,0,2
99,22q11.2 copy number variation syndrome WP4657,0.17955107863347383,1.345094509450945,2.3099248166219213,"['RTN4R', 'RANBP1', 'RTL10', 'OAT', 'SERPIND1', 'EMC10', 'RTN4', 'SLC7A4', 'ACTA2', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'DGCR6L', 'RAN', 'FGF10']",0.9389757168811431,0,0,16
100,Complement and Coagulation Cascades WP558,0.18031589612908158,1.8478581979320532,3.1654642240816573,"['CPB2', 'SERPIND1', 'F12', 'SERPING1', 'CLU']",0.9389757168811431,0,0,5
101,16p11.2 proximal deletion syndrome WP4949,0.18586795897453895,1.3868017795353436,2.333597364379897,"['IGFBP3', 'SEZ6L2', 'PPP2CA', 'CCT6A', 'PPP2R1A', 'TCP1', 'TMEM219', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9389757168811431,0,0,13
102,Development and heterogeneity of the ILC family WP3893,0.18750479229212863,2.375166889185581,3.975912692439719,"['IL7', 'ID2', 'IL18']",0.9389757168811431,0,0,3
103,Dopamine metabolism WP2436,0.18750479229212863,2.375166889185581,3.975912692439719,"['PPP2CA', 'TYR', 'SOD1']",0.9389757168811431,0,0,3
104,Dopaminergic Neurogenesis WP2855,0.18750479229212863,2.375166889185581,3.975912692439719,"['NEUROD1', 'ALDH1A1', 'SLC18A2']",0.9389757168811431,0,0,3
105,Pyrimidine metabolism WP4022,0.19099827462930008,1.3421972514405196,2.2219953147335785,"['RRM2', 'NME2', 'NME1', 'POLE4', 'UCK1', 'POLD2', 'POLE3', 'POLR2E', 'POLR1E', 'CMPK2', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2K', 'POLR2L']",0.9389757168811431,0,0,15
106,Osteoblast differentiation WP4787,0.19278644203427175,1.3249002512191517,2.181013988725427,"['FZD1', 'PRKCH', 'JAG1', 'NOTCH4', 'PRKCD', 'WNT7A', 'PIK3C2G', 'FGF1', 'DLL3', 'FGF7', 'HEY1', 'PRKCQ', 'PPARG', 'WNT2', 'FGF10', 'MAPK3']",0.9389757168811431,0,0,16
107,7q11.23 copy number variation syndrome WP4932,0.19417547178512545,1.310013207858676,2.1471025234239915,"['H2AFX', 'HMGA1', 'ATP5MC3', 'VPS37D', 'UBE2L6', 'NRG1', 'ACACB', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'WNT2', 'GAPDH', 'MAPK3']",0.9389757168811431,0,0,17
108,Oncostatin M Signaling Pathway WP2374,0.19438870934460903,1.4187884008039047,2.323827091934142,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'PRKCD', 'RPS6', 'TIMP3', 'FOS', 'HRAS', 'MAPK3']",0.9389757168811431,0,0,11
109,Development of ureteric collection system WP5053,0.19702515042307542,1.663152709359606,2.701664995915325,"['GRIP1', 'FRAS1', 'GFRA1', 'SPRY1', 'FAT4', 'ETV4']",0.9389757168811431,0,0,6
110,Nuclear receptors WP170,0.19702515042307542,1.663152709359606,2.701664995915325,"['NR4A1', 'AR', 'THRA', 'ESRRB', 'PPARG', 'NR2F6']",0.9389757168811431,0,0,6
111,Oxidation by Cytochrome P450 WP43,0.19702515042307542,1.663152709359606,2.701664995915325,"['CYP39A1', 'CYP26B1', 'CYP1B1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.9389757168811431,0,0,6
112,White fat cell differentiation WP4149,0.2088121220222889,1.7322131954702118,2.7132008115095343,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG']",0.9519585918699014,0,0,5
113,Proteasome Degradation WP183,0.21166418958388222,1.3864197530864197,2.152769193806919,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'PSMD2', 'PSMD3', 'H2AFX', 'UBC', 'PSME1', 'HLA-C', 'PSMB10']",0.9519585918699014,0,0,11
114,Methionine De Novo and Salvage Pathway WP3580,0.22047477984576058,1.8474409448818898,2.793278920741511,"['AHCY', 'AMD1', 'ODC1', 'MAT2B']",0.9519585918699014,0,0,4
115,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.22283314072964286,1.5838142153413088,2.377831019690312,"['NDUFA13', 'HSP90AA1', 'IL18', 'RAC1', 'NLRP1', 'AAMP']",0.9519585918699014,0,0,6
116,Prostaglandin Synthesis and Regulation WP98,0.22283314072964286,1.5838142153413088,2.377831019690312,"['HSD11B1', 'HSD11B2', 'S100A6', 'MITF', 'PPARG', 'PTGES']",0.9519585918699014,0,0,6
117,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.22283314072964286,1.5838142153413088,2.377831019690312,"['CREB3', 'STAR', 'CALM3', 'CALM1', 'PLCB2', 'CALM2']",0.9519585918699014,0,0,6
118,GDNF/RET signaling axis WP4830,0.23019092748919343,2.0780865715691097,3.0523895533207375,"['GFRA1', 'SPRY1', 'FAT4']",0.9519585918699014,0,0,3
119,RalA downstream regulated genes WP2290,0.23019092748919343,2.0780865715691097,3.0523895533207375,"['EXOC8', 'RAC1', 'HRAS']",0.9519585918699014,0,0,3
120,RAS and bradykinin pathways in COVID-19 WP4969,0.23019092748919343,2.0780865715691097,3.0523895533207375,"['F12', 'SERPING1', 'NOS1']",0.9519585918699014,0,0,3
121,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.23019092748919343,2.0780865715691097,3.0523895533207375,"['PTTG1', 'ANAPC11', 'MAD2L1']",0.9519585918699014,0,0,3
122,ACE Inhibitor Pathway WP554,0.2304852889647705,2.770403146509341,4.06575567219798,"['MAS1', 'ATP6AP2']",0.9519585918699014,0,0,2
123,Drug Induction of Bile Acid Pathway WP2289,0.2304852889647705,2.770403146509341,4.06575567219798,"['ABCB1', 'SLC10A1']",0.9519585918699014,0,0,2
124,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2304852889647705,2.770403146509341,4.06575567219798,"['CEBPB', 'ALDH1A1']",0.9519585918699014,0,0,2
125,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.2304852889647705,2.770403146509341,4.06575567219798,"['E2F1', 'BAX']",0.9519585918699014,0,0,2
126,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.2304852889647705,2.770403146509341,4.06575567219798,"['AHCY', 'MAT2B']",0.9519585918699014,0,0,2
127,Peroxiredoxin 2 induced ovarian failure WP4873,0.2304852889647705,2.770403146509341,4.06575567219798,"['STAR', 'BAX']",0.9519585918699014,0,0,2
128,Tamoxifen metabolism WP691,0.2304852889647705,2.770403146509341,4.06575567219798,"['CYP1B1', 'CYP3A5']",0.9519585918699014,0,0,2
129,Parkinson's disease pathway WP2371,0.2321411310987094,1.4925124161201047,2.179679712211354,"['PINK1', 'CCNE2', 'CASP6', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.9519585918699014,0,0,7
130,Adipogenesis WP236,0.2351026111425751,1.2572758791480931,1.820200053149129,"['FZD1', 'GDF10', 'CEBPA', 'EGR2', 'CDKN1A', 'CEBPB', 'GADD45B', 'ASIP', 'HMGA1', 'LPL', 'MIF', 'CYP26B1', 'DDIT3', 'E2F1', 'NDN', 'PPARG', 'MEF2D']",0.9566867791878633,0,0,17
131,Physiological and pathological hypertrophy of the heart WP1528,0.23863343174804336,1.6301734874156457,2.3357560378214877,"['JUN', 'RAC1', 'FOS', 'CALM1', 'CALM2']",0.9636418732420987,0,0,5
132,Nanomaterial induced apoptosis WP2507,0.25591030308531026,1.7051786795881283,2.324036235438336,"['ENDOG', 'CASP6', 'BAX', 'CYCS']",0.9999294775799197,0,0,4
133,Vitamin B12 metabolism WP1533,0.25591030308531026,1.7051786795881283,2.324036235438336,"['CUBN', 'HBA1', 'SOD2', 'SOD1']",0.9999294775799197,0,0,4
134,Prader-Willi and Angelman Syndrome WP3998,0.26125651620329005,1.3858481262327416,1.8601581586335083,"['MAGEL2', 'CDKN2C', 'CDKN2A', 'E2F1', 'NDN', 'GHRL', 'TYR', 'GABRD']",0.9999294775799197,0,0,8
135,Major receptors targeted by epinephrine and norepinephrine WP4589,0.27438742163877805,1.8470241023118543,2.388597840607751,"['ADCY10', 'ADRA1D', 'ADRA2C']",0.9999294775799197,0,0,3
136,Overview of nanoparticle effects WP3287,0.27438742163877805,1.8470241023118543,2.388597840607751,"['LAMA3', 'FN1', 'BAX']",0.9999294775799197,0,0,3
137,COVID-19 adverse outcome pathway WP4891,0.2825456244803704,5.53955773955774,7.001531443518692,['IL7'],0.9999294775799197,0,0,1
138,Gastric acid production WP2596,0.2825456244803704,5.53955773955774,7.001531443518692,['CCK'],0.9999294775799197,0,0,1
139,Nanomaterial-induced inflammasome activation WP3890,0.2825456244803704,5.53955773955774,7.001531443518692,['CTSB'],0.9999294775799197,0,0,1
140,Thyroxine (Thyroid Hormone) Production WP1981,0.2825456244803704,5.53955773955774,7.001531443518692,['TSHR'],0.9999294775799197,0,0,1
141,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.2846163035054888,1.343733189887036,1.6885530105383864,"['CDKN1A', 'FGF7', 'HSP90AA1', 'JUN', 'CDKN2A', 'BAX', 'FOS', 'ELK1']",0.9999294775799197,0,0,8
142,Corticotropin-releasing hormone signaling pathway WP2355,0.2848834841191067,1.2426747575297867,1.5603956385364568,"['GNAZ', 'HSP90AA1', 'JUND', 'PRKCD', 'IL18', 'FOS', 'ELK1', 'FOSL2', 'NR4A1', 'STAR', 'FOSB', 'PRKCQ', 'MAPK3']",0.9999294775799197,0,0,13
143,Bile acids synthesis and enterohepatic circulation  WP4389,0.29171141142877033,2.216125860373648,2.7302455246574158,"['SLC10A1', 'MAPK3']",0.9999294775799197,0,0,2
144,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.29171141142877033,2.216125860373648,2.7302455246574158,"['BATF3', 'ID2']",0.9999294775799197,0,0,2
145,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.29171141142877033,2.216125860373648,2.7302455246574158,"['JUN', 'IRAK1']",0.9999294775799197,0,0,2
146,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.29171141142877033,2.216125860373648,2.7302455246574158,"['ELK1', 'MEF2D']",0.9999294775799197,0,0,2
147,Nucleotide metabolism WP404,0.29236166216596277,1.5832395950506186,1.947010541304935,"['PRPS1', 'RRM2', 'NME2', 'OAZ1']",0.9999294775799197,0,0,4
148,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.29236166216596277,1.5832395950506186,1.947010541304935,"['HTR2B', 'ELK1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,4
149,Zinc homeostasis WP3529,0.29236166216596277,1.5832395950506186,1.947010541304935,"['SLC30A1', 'SLC39A7', 'SLC39A1', 'SLC39A3']",0.9999294775799197,0,0,4
150,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3074212329448678,1.2597594902629454,1.485932145758183,"['ANGPT2', 'BAD', 'STMN1', 'FN1', 'BAX', 'NOS1', 'RAC1', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9999294775799197,0,0,10
151,Glycogen Synthesis and Degradation WP500,0.3077877979725855,1.3377576859672677,1.5763396805849585,"['PPP2CA', 'GSK3A', 'PPP2R1A', 'PHKA1', 'CALM3', 'CALM1', 'CALM2']",0.9999294775799197,0,0,7
152,Eukaryotic Transcription Initiation WP405,0.3084801585494918,1.3040956027381367,1.5337439088469242,"['TAF13', 'POLR2E', 'POLR1E', 'TAF7', 'POLR3H', 'TAF6', 'POLR2I', 'POLR2K']",0.9999294775799197,0,0,8
153,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.3084801585494918,1.3040956027381367,1.5337439088469242,"['CEBPA', 'CDKN1A', 'CEBPB', 'ICMT', 'E2F1', 'PPARG', 'EMD', 'ACTB']",0.9999294775799197,0,0,8
154,Small cell lung cancer WP4658,0.3183766919923527,1.1939891957696112,1.36654455163413,"['CDKN1A', 'CDKN1B', 'GADD45B', 'LAMA4', 'LAMA3', 'FN1', 'FHIT', 'CKS1B', 'CCNE2', 'CKS2', 'E2F1', 'CYCS', 'BAX', 'SKP1']",0.9999294775799197,0,0,14
155,BMP Signaling Pathway in Eyelid Development WP3927,0.3193150986811766,1.6621741269060502,1.8974995763505347,"['JUN', 'MAPK3', 'FGF10']",0.9999294775799197,0,0,3
156,Nicotine Activity on Dopaminergic Neurons WP1602,0.3193150986811766,1.6621741269060502,1.8974995763505347,"['CHRNB2', 'PPP1R1B', 'SLC18A2']",0.9999294775799197,0,0,3
157,Tryptophan catabolism leading to NAD+ production WP4210,0.3193150986811766,1.6621741269060502,1.8974995763505347,"['TDO2', 'HAAO', 'KMO']",0.9999294775799197,0,0,3
158,Type II diabetes mellitus WP1584,0.3193150986811766,1.6621741269060502,1.8974995763505347,"['SURF1', 'KCNJ11', 'PRKCD']",0.9999294775799197,0,0,3
159,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3262865890645811,1.2193975308641976,1.365699842131371,"['EGR1', 'JUN', 'CDKN1B', 'APEX1', 'RPS6', 'E2F1', 'FOS', 'HRAS', 'TSHR', 'MYL12B', 'MAPK3']",0.9999294775799197,0,0,11
160,DNA damage response WP707,0.3287005726267837,1.2316551497203028,1.370349442061199,"['CDKN1A', 'CDKN1B', 'CCNE2', 'GADD45B', 'H2AFX', 'E2F1', 'CYCS', 'BAX', 'BBC3', 'RAD9A']",0.9999294775799197,0,0,10
161,IL-7 signaling pathway WP205,0.32941634099526923,1.4775590551181101,1.640730118682814,"['CDKN1B', 'BAD', 'IL7', 'MAPK3']",0.9999294775799197,0,0,4
162,Glycosylation and related congenital defects WP4521,0.33336392295129463,1.3852781880846874,1.5217565210948187,"['DPM3', 'MPI', 'DOLK', 'MGAT2', 'MPDU1']",0.9999294775799197,0,0,5
163,Common Pathways Underlying Drug Addiction WP2636,0.3340441312079681,1.2930507639231148,1.4178071015579112,"['PPP1CC', 'PPP1R1A', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999294775799197,0,0,7
164,IL-5 signaling pathway WP127,0.3344641751875939,1.3299310344827586,1.4565743885082192,"['GSK3A', 'JUN', 'RPS6', 'FOS', 'ELK1', 'MAPK3']",0.9999294775799197,0,0,6
165,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3378054109919139,1.1293721725697892,1.2256909678858954,"['NSF', 'SHC4', 'VAV3', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'EEF2', 'ELK1', 'ACACB', 'PPP2CA', 'GRIP1', 'MARCKS', 'CFL1', 'RAC1', 'HRAS', 'MAPK3', 'CDK5R1']",0.9999294775799197,0,0,22
166,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.3522203250047836,1.8466076696165192,1.9269321041384593,"['JAG1', 'WNT2']",0.9999294775799197,0,0,2
167,Blood Clotting Cascade WP272,0.3522203250047836,1.8466076696165192,1.9269321041384593,"['F8A1', 'F12']",0.9999294775799197,0,0,2
168,Farnesoid X receptor pathway WP2879,0.3522203250047836,1.8466076696165192,1.9269321041384593,"['SLC10A1', 'FKBP5']",0.9999294775799197,0,0,2
169,PI3K-Akt signaling pathway WP4172,0.353411339404493,1.0897599510316274,1.1334839896171236,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'FLT3', 'LAMA4', 'LAMA3', 'FGF1', 'HSP90B1', 'PPP2CA', 'GNG10', 'FGF7', 'GNG3', 'PPP2R1A', 'PDGFD', 'RAC1', 'HRAS', 'MAPK3', 'HSP90AA1', 'ANGPT2', 'ITGA4', 'BAD', 'RPS6', 'FN1', 'EPOR', 'EFNA1', 'CREB3', 'EFNA3', 'CCNE2', 'LPAR6', 'IL7', 'ITGA10', 'COL6A6', 'FGF10']",0.9999294775799197,0,0,34
170,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.35728700138194713,1.2314266929651545,1.26740392560419,"['PPP1CC', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'PPP1R1A', 'DDIT3', 'PPP1R1B']",0.9999294775799197,0,0,8
171,Synaptic Vesicle Pathway WP2267,0.35728700138194713,1.2314266929651545,1.26740392560419,"['NSF', 'RAB3A', 'SLC17A7', 'PARK7', 'SYN3', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9999294775799197,0,0,8
172,Wnt signaling pathway and pluripotency WP399,0.3582863288440293,1.1620876054406581,1.1927932266182628,"['FZD1', 'JUN', 'PRKCH', 'PRKCD', 'ESRRB', 'WNT7A', 'PPM1J', 'ZBTB33', 'PPP2CA', 'FRAT1', 'PPP2R1A', 'PRKCQ', 'WNT2']",0.9999294775799197,0,0,13
173,PDGF Pathway WP2526,0.36059176775020074,1.2512281594301977,1.2762637306554014,"['JUN', 'ARFIP2', 'RAC1', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,7
174,G13 Signaling Pathway WP524,0.3635501544833232,1.278666161424782,1.29380303056759,"['CFL2', 'CFL1', 'ARHGDIG', 'RAC1', 'CALM1', 'CALM2']",0.9999294775799197,0,0,6
175,Alpha 6 Beta 4 signaling pathway WP244,0.36582552807965096,1.3191953295350636,1.3265811855650267,"['LAMA3', 'PRKCD', 'RAC1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,5
176,Endothelin Pathways WP2197,0.36582552807965096,1.3191953295350636,1.3265811855650267,"['ADCY10', 'GNA15', 'ATP2A2', 'CALM1', 'CALM2']",0.9999294775799197,0,0,5
177,The influence of laminopathies on Wnt signaling WP4844,0.36582552807965096,1.3191953295350636,1.3265811855650267,"['CEBPA', 'CEBPB', 'ICMT', 'PPARG', 'EMD']",0.9999294775799197,0,0,5
178,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3666914435923608,1.3850885826771653,1.3895687039337568,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999294775799197,0,0,4
179,Urea cycle and associated pathways WP4595,0.3666914435923608,1.3850885826771653,1.3895687039337568,"['OAT', 'GOT1', 'MDH2', 'NOS1']",0.9999294775799197,0,0,4
180,miRNA regulation of DNA damage response WP1530,0.37200994458743,1.1790342567893974,1.165869976528686,"['CDKN1A', 'CDKN1B', 'CCNE2', 'GADD45B', 'H2AFX', 'E2F1', 'CYCS', 'BAX', 'BBC3', 'RAD9A']",0.9999294775799197,0,0,10
181,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3820158346118955,1.1980382749613518,1.1528641085423175,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'JUND', 'HSPA5', 'HSPB1', 'NRG1']",0.9999294775799197,0,0,8
182,Retinoblastoma gene in cancer WP2446,0.38244708552857626,1.1465176502657761,1.1019926072475048,"['CDKN1A', 'CDKN1B', 'RRM2', 'CCNE2', 'TFDP2', 'H2AFZ', 'SUV39H1', 'RPA3', 'STMN1', 'MCM3', 'E2F1', 'MCM4']",0.9999294775799197,0,0,12
183,Metapathway biotransformation Phase I and II WP702,0.3847595448435205,1.1233400644583227,1.0729433206397674,"['GSTM4', 'CHST9', 'GPX4', 'GSTP1', 'GLYAT', 'CYP2C18', 'CYP3A5', 'CYP3A7', 'CYP39A1', 'CYP26B1', 'CYP1B1', 'CHST1', 'NAT8L', 'SULT4A1', 'CHST2']",0.9999294775799197,0,0,15
184,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.38801468948148504,1.1500675518285581,1.088782844807387,"['CDKN1A', 'JUN', 'GADD45B', 'DCC', 'BAD', 'CYCS', 'BAX', 'RAC1', 'FOS', 'BBC3', 'MAPK3']",0.9999294775799197,0,0,11
185,let-7 inhibition of ES cell reprogramming WP3299,0.3923093092822951,2.7695331695331697,2.5914651925701313,['EGR1'],0.9999294775799197,0,0,1
186,Macrophage markers WP4146,0.3923093092822951,2.7695331695331697,2.5914651925701313,['CD83'],0.9999294775799197,0,0,1
187,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.3923093092822951,2.7695331695331697,2.5914651925701313,['FURIN'],0.9999294775799197,0,0,1
188,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.3923093092822951,2.7695331695331697,2.5914651925701313,['MAS1'],0.9999294775799197,0,0,1
189,p38 MAPK Signaling Pathway WP400,0.3927521517876619,1.2311986863711002,1.1506493875410868,"['DDIT3', 'HSPB1', 'RAC1', 'ELK1', 'HRAS', 'MEF2D']",0.9999294775799197,0,0,6
190,Cardiac Progenitor Differentiation WP2406,0.40383950810427677,1.30349698934692,1.1819299104581418,"['MESP1', 'ACTC1', 'NRG1', 'THY1']",0.9999294775799197,0,0,4
191,Male infertility WP4673,0.40858559438603764,1.1082096933728982,0.9919073562628338,"['ABCB1', 'HMGA1', 'TEX15', 'SOD2', 'CLU', 'ETV5', 'AR', 'CCNA1', 'CYP26B1', 'SPATA17', 'MSH4', 'NOS1', 'TRIP13', 'RAG1']",0.9999294775799197,0,0,14
192,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.40874465929558196,1.3848991637973438,1.239020287994183,"['JUN', 'PRKCQ', 'MAPK3']",0.9999294775799197,0,0,3
193,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.40874465929558196,1.3848991637973438,1.239020287994183,"['FGF7', 'SUV39H1', 'FN1']",0.9999294775799197,0,0,3
194,Estrogen Receptor Pathway WP2881,0.4107992232813254,1.5826661047899986,1.4080199948186645,"['JUN', 'CYP1B1']",0.9999294775799197,0,0,2
195,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4107992232813254,1.5826661047899986,1.4080199948186645,"['PRKCQ', 'MAFK']",0.9999294775799197,0,0,2
196,Genes targeted by miRNAs in adipocytes WP1992,0.4107992232813254,1.5826661047899986,1.4080199948186645,"['TMSB4X', 'KCNJ2']",0.9999294775799197,0,0,2
197,miR-509-3p alteration of YAP1/ECM axis WP3967,0.4107992232813254,1.5826661047899986,1.4080199948186645,"['SPARC', 'FN1']",0.9999294775799197,0,0,2
198,Neuroinflammation WP4919,0.4107992232813254,1.5826661047899986,1.4080199948186645,"['JUN', 'FOS']",0.9999294775799197,0,0,2
199,Purine metabolism WP4792,0.4107992232813254,1.5826661047899986,1.4080199948186645,"['PRPS1', 'APRT']",0.9999294775799197,0,0,2
200,Thiamine metabolic pathways WP4297,0.4107992232813254,1.5826661047899986,1.4080199948186645,"['BCKDK', 'SLC19A3']",0.9999294775799197,0,0,2
201,TNF-alpha signaling pathway WP231,0.41517342949943564,1.1081562036579338,0.9741346217757129,"['HSP90AA1', 'JUN', 'BAD', 'PPP2CA', 'SMPD2', 'PSMD2', 'RFK', 'BAX', 'RAC1', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999294775799197,0,0,13
202,DNA Replication WP466,0.4219066257014506,1.1871217452498242,1.0244519429763517,"['RPA3', 'UBC', 'POLD2', 'MCM3', 'MCM4', 'UBA52']",0.9999294775799197,0,0,6
203,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4219066257014506,1.1871217452498242,1.0244519429763517,"['BAD', 'NEFL', 'CYCS', 'NOS1', 'CALM1', 'CALM2']",0.9999294775799197,0,0,6
204,DNA damage response (only ATM dependent) WP710,0.4269123727437571,1.0925035873002604,0.9299133828111475,"['JUN', 'CDKN1A', 'CDKN1B', 'CDKN2A', 'BAD', 'WNT7A', 'PIK3C2G', 'SOD2', 'BBC3', 'FRAT1', 'BAX', 'RAC1', 'WNT2', 'HRAS']",0.9999294775799197,0,0,14
205,Leptin signaling pathway WP2034,0.4296844145428178,1.1080493827160494,0.9359740332205013,"['GSK3A', 'BAD', 'CFL2', 'RPS6', 'LEPR', 'BAX', 'RAC1', 'ELK1', 'HRAS', 'ACACB', 'MAPK3']",0.9999294775799197,0,0,11
206,PDGFR-beta pathway WP3972,0.4306406814797749,1.204268619013979,1.014573698063401,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,5
207,Prion disease pathway WP3995,0.4306406814797749,1.204268619013979,1.014573698063401,"['PRNP', 'HSPA5', 'ELK1', 'HSP90B1', 'MAPK3']",0.9999294775799197,0,0,5
208,7-oxo-C and 7beta-HC pathways WP5064,0.44055195611491366,1.230971128608924,1.0090601380287367,"['HSD11B1', 'HSD11B2', 'DBP', 'ACOT4']",0.9999294775799197,0,0,4
209,DNA Mismatch Repair WP531,0.44055195611491366,1.230971128608924,1.0090601380287367,"['POLE4', 'RPA3', 'POLD2', 'POLE3']",0.9999294775799197,0,0,4
210,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.44055195611491366,1.230971128608924,1.0090601380287367,"['PPP2CA', 'CDKN1A', 'THRA', 'MAPK3']",0.9999294775799197,0,0,4
211,Unfolded protein response WP4925,0.44055195611491366,1.230971128608924,1.0090601380287367,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.9999294775799197,0,0,4
212,Acute viral myocarditis WP4298,0.4465820905595175,1.1079427725703008,0.8931481698128176,"['ENDOG', 'CASP6', 'CYCS', 'BAX', 'NOS1', 'ACTB', 'SGCG', 'EIF4G2', 'MAPK3']",0.9999294775799197,0,0,9
213,Copper homeostasis WP3286,0.45086118517546114,1.1460845931713946,0.9129661507414408,"['PRNP', 'JUN', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999294775799197,0,0,6
214,Fas ligand pathway and stress induction of heat shock proteins WP314,0.45086118517546114,1.1460845931713946,0.9129661507414408,"['JUN', 'CASP6', 'HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.9999294775799197,0,0,6
215,IL-3 signaling pathway WP286,0.45086118517546114,1.1460845931713946,0.9129661507414408,"['JUN', 'YWHAB', 'BAD', 'FOS', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,6
216,Transcription factor regulation in adipogenesis WP3599,0.45219153728868566,1.2782549472170721,1.0144863151687353,"['CEBPA', 'CEBPB', 'PPARG']",0.9999294775799197,0,0,3
217,Urea cycle and metabolism of amino groups WP497,0.45219153728868566,1.2782549472170721,1.0144863151687353,"['OAT', 'ODC1', 'CKB']",0.9999294775799197,0,0,3
218,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4562792466374292,1.1078895463510847,0.8693058360184497,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'HRAS', 'PLCB2', 'MAPK3']",0.9999294775799197,0,0,8
219,Notch Signaling Pathway Netpath WP61,0.4562792466374292,1.1078895463510847,0.8693058360184497,"['PSENEN', 'CDKN1A', 'JAG1', 'MAML2', 'HEY1', 'NOTCH4', 'SKP1', 'DLL3']",0.9999294775799197,0,0,8
220,Apoptosis WP254,0.4596360265974787,1.0861738574995645,0.8443050422327705,"['JUN', 'CRADD', 'CASP6', 'CDKN2A', 'BAD', 'CYCS', 'BAX', 'NFKBIE', 'BCL2L2', 'BBC3']",0.9999294775799197,0,0,10
221,Melatonin metabolism and effects WP3298,0.46257841048491843,1.1539881831610044,0.8896547269844954,"['PER2', 'IRAK1', 'CYP1B1', 'CALM1', 'CALM2']",0.9999294775799197,0,0,5
222,Cysteine and methionine catabolism WP4504,0.4666228066086501,1.384709931170108,1.055473048252138,"['AHCY', 'GOT1']",0.9999294775799197,0,0,2
223,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4666228066086501,1.384709931170108,1.055473048252138,"['GABBR1', 'GRM4']",0.9999294775799197,0,0,2
224,ID signaling pathway WP53,0.4666228066086501,1.384709931170108,1.055473048252138,"['ID2', 'ELK1']",0.9999294775799197,0,0,2
225,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.4682380736637074,1.0306828204057001,0.7820598696215035,"['CDKN1A', 'CDKN1B', 'CHRM1', 'HSP90AB1', 'LAMA4', 'LAMA3', 'SLC2A3', 'FGF1', 'HSP90B1', 'PPP2CA', 'GNG10', 'FGF7', 'GNG3', 'PPP2R1A', 'PDGFD', 'NOS1', 'PELO', 'HRAS', 'MAPK3', 'HSP90AA1', 'ANGPT2', 'ITGA4', 'BAD', 'RPS6', 'FN1', 'EPOR', 'EFNA1', 'CREB3', 'EFNA3', 'LPAR6', 'ITGA10', 'FGF10']",0.9999294775799197,0,0,32
226,G Protein Signaling Pathways WP35,0.4722613366294301,1.058983454973685,0.7944734981372678,"['GNAZ', 'PRKCH', 'PRKCD', 'AKAP5', 'GNG10', 'GNG3', 'GNA15', 'PRKD3', 'PRKAR1A', 'PRKCQ', 'CALM1', 'HRAS', 'CALM2']",0.9999294775799197,0,0,13
227,Oxidative Stress WP408,0.4765606095256576,1.1660795690012433,0.864251960905382,"['NOX5', 'FOS', 'SOD2', 'SOD1']",0.9999294775799197,0,0,4
228,Codeine and Morphine Metabolism WP1604,0.4852871567898356,1.846191646191646,1.3348233067080204,['ABCB1'],0.9999294775799197,0,0,1
229,Composition of Lipid Particles WP3601,0.4852871567898356,1.846191646191646,1.3348233067080204,['LPL'],0.9999294775799197,0,0,1
230,Fatty Acid Omega Oxidation WP206,0.4852871567898356,1.846191646191646,1.3348233067080204,['ALDH1A1'],0.9999294775799197,0,0,1
231,Irinotecan pathway WP229,0.4852871567898356,1.846191646191646,1.3348233067080204,['CYP3A5'],0.9999294775799197,0,0,1
232,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4852871567898356,1.846191646191646,1.3348233067080204,['SELP'],0.9999294775799197,0,0,1
233,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.4852871567898356,1.846191646191646,1.3348233067080204,['RAC1'],0.9999294775799197,0,0,1
234,Role of Osx and miRNAs in tooth development WP3971,0.4852871567898356,1.846191646191646,1.3348233067080204,['NOTCH4'],0.9999294775799197,0,0,1
235,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4852871567898356,1.846191646191646,1.3348233067080204,['DLL3'],0.9999294775799197,0,0,1
236,Sulindac Metabolic Pathway WP2542,0.4852871567898356,1.846191646191646,1.3348233067080204,['CYP1B1'],0.9999294775799197,0,0,1
237,Vitamin B6-dependent and responsive disorders WP4228,0.4852871567898356,1.846191646191646,1.3348233067080204,['PNPO'],0.9999294775799197,0,0,1
238,Bladder cancer WP2828,0.49396063729414114,1.107730182176268,0.7812814844264735,"['CDKN1A', 'CDKN2A', 'DAPK2', 'E2F1', 'HRAS']",0.9999294775799197,0,0,5
239,Neural Crest Cell Migration during Development WP4564,0.49396063729414114,1.107730182176268,0.7812814844264735,"['ARF1', 'JUN', 'RAC1', 'FOS', 'EPHB3']",0.9999294775799197,0,0,5
240,Constitutive Androstane Receptor Pathway WP2875,0.4942517816344752,1.1868456187196965,0.8363822278339729,"['HSP90AA1', 'ABCB1', 'CYP3A5']",0.9999294775799197,0,0,3
241,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.4942517816344752,1.1868456187196965,0.8363822278339729,"['ANGPT2', 'LTBP1', 'MAPK3']",0.9999294775799197,0,0,3
242,Triacylglyceride synthesis WP325,0.4942517816344752,1.1868456187196965,0.8363822278339729,"['MOGAT1', 'LPL', 'AGPAT1']",0.9999294775799197,0,0,3
243,Glioblastoma signaling pathways WP2261,0.5012376843325252,1.038475790513834,0.717249132206728,"['CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CDKN2A', 'PRKCD', 'E2F1', 'PIK3C2G', 'PRKCQ', 'FOXO4', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,12
244,Integrated Cancer Pathway WP1971,0.5076239125969879,1.0719529636103606,0.7267995830936113,"['CDKN1A', 'CDKN1B', 'BAD', 'E2F1', 'BAX', 'BBC3']",0.9999294775799197,0,0,6
245,Endometrial cancer WP4155,0.5151014256965682,1.0384188455846077,0.6888781884657869,"['CDKN1A', 'GADD45B', 'BAD', 'BAX', 'FOS', 'FGF1', 'ELK1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,9
246,Ebola Virus Pathway on Host WP4217,0.517808111460813,1.0201728356499558,0.671427309356732,"['VPS18', 'CAV3', 'ITGA4', 'CAV2', 'VPS4A', 'HLA-C', 'ACTB', 'ACTG1', 'RHOB', 'TYRO3', 'RAC1', 'CTSB', 'HLA-DQB1', 'MAPK3']",0.9999294775799197,0,0,14
247,IL-4 signaling pathway WP395,0.5189690399305181,1.0477668402754652,0.687241849312311,"['CEBPA', 'CEBPB', 'BAD', 'FOS', 'ELK1', 'MAPK3', 'SOCS5']",0.9999294775799197,0,0,7
248,Phosphodiesterases in neuronal function WP4222,0.5189690399305181,1.0477668402754652,0.687241849312311,"['ADCY10', 'PDE10A', 'ADORA2A', 'PPP1R1B', 'PDE6C', 'PDE5A', 'NOS1']",0.9999294775799197,0,0,7
249,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5191631955222451,1.2307440183546379,0.8067982452566288,"['CDKN1A', 'ROS1']",0.9999294775799197,0,0,2
250,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5191631955222451,1.2307440183546379,0.8067982452566288,"['JAG1', 'E2F1']",0.9999294775799197,0,0,2
251,"NAD metabolism, sirtuins and aging WP3630",0.5191631955222451,1.2307440183546379,0.8067982452566288,"['PPARG', 'ROS1']",0.9999294775799197,0,0,2
252,IL-2 signaling pathway WP49,0.5246330183588197,1.0650304889595879,0.6870045983334224,"['JUN', 'RPS6', 'FOS', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,5
253,Oxidative Damage WP3941,0.5246330183588197,1.0650304889595879,0.6870045983334224,"['CDKN1A', 'CDKN1B', 'BAD', 'CYCS', 'NFKBIE']",0.9999294775799197,0,0,5
254,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5287375791507118,1.030319710105041,0.656584670494866,"['FZD1', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'CSNK2B', 'WNT7A', 'WNT2']",0.9999294775799197,0,0,8
255,Apoptosis Modulation by HSP70 WP384,0.5346297829454261,1.1076242006886374,0.6935729705595594,"['CASP6', 'CYCS', 'HSPA1A']",0.9999294775799197,0,0,3
256,Globo Sphingolipid Metabolism WP1424,0.5346297829454261,1.1076242006886374,0.6935729705595594,"['B3GALNT1', 'FUT2', 'FUT1']",0.9999294775799197,0,0,3
257,Heart Development WP1591,0.5346297829454261,1.1076242006886374,0.6935729705595594,"['HEY1', 'BHLHE40', 'FGF10']",0.9999294775799197,0,0,3
258,Monoamine Transport WP727,0.5346297829454261,1.1076242006886374,0.6935729705595594,"['TDO2', 'ADORA2A', 'NOS1']",0.9999294775799197,0,0,3
259,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5346297829454261,1.1076242006886374,0.6935729705595594,"['PTGES2', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,3
260,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5346297829454261,1.1076242006886374,0.6935729705595594,"['EGR1', 'ELK1', 'MAPK3']",0.9999294775799197,0,0,3
261,TYROBP causal network in microglia WP3945,0.5346297829454261,1.1076242006886374,0.6935729705595594,"['RBM47', 'IL18', 'SFT2D2']",0.9999294775799197,0,0,3
262,TGF-beta Receptor Signaling WP560,0.5351924256805676,1.0383620689655173,0.6491101614246042,"['FKBP1A', 'JUN', 'FOS', 'HRAS', 'LTBP1', 'MAPK3']",0.9999294775799197,0,0,6
263,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5485734144321913,0.9954388697296696,0.5976955039700688,"['FZD1', 'SPARC', 'JAG1', 'NOTCH4', 'EIF5A2', 'FN1', 'WNT7A', 'DLL3', 'CLDN20', 'MMP15', 'ID2', 'STRAP', 'WNT2', 'HRAS', 'MEF2D', 'MAPK3']",0.9999294775799197,0,0,16
264,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.5521186597768647,1.0068136991213914,0.5980395772035982,"['CACNB3', 'ITGA4', 'ITGA10', 'ATP2A2', 'EMD', 'ACTB', 'SGCG', 'ACTG1']",0.9999294775799197,0,0,8
265,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5544631615493373,1.0254937359811807,0.6047899658021668,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,5
266,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5620823877233558,1.006806986117331,0.580028393738998,"['ACAN', 'THRA', 'TIMP3', 'CALM1', 'SLC38A2', 'CALM2']",0.9999294775799197,0,0,6
267,Endochondral Ossification WP474,0.5620823877233558,1.006806986117331,0.580028393738998,"['ACAN', 'THRA', 'TIMP3', 'CALM1', 'SLC38A2', 'CALM2']",0.9999294775799197,0,0,6
268,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.5640451017109754,1.3845208845208845,0.7928058207904948,['IRAK1'],0.9999294775799197,0,0,1
269,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.5640451017109754,1.3845208845208845,0.7928058207904948,['GSTP1'],0.9999294775799197,0,0,1
270,Cytokines and Inflammatory Response WP530,0.5640451017109754,1.3845208845208845,0.7928058207904948,['IL7'],0.9999294775799197,0,0,1
271,LTF danger signal response pathway WP4478,0.5640451017109754,1.3845208845208845,0.7928058207904948,['IRAK1'],0.9999294775799197,0,0,1
272,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5640451017109754,1.3845208845208845,0.7928058207904948,['FN1'],0.9999294775799197,0,0,1
273,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5640451017109754,1.3845208845208845,0.7928058207904948,['HEY1'],0.9999294775799197,0,0,1
274,PTF1A related regulatory pathway WP4147,0.5640451017109754,1.3845208845208845,0.7928058207904948,['FGF10'],0.9999294775799197,0,0,1
275,SARS-CoV-2 and COVID-19 Pathway WP4846,0.5640451017109754,1.3845208845208845,0.7928058207904948,['FURIN'],0.9999294775799197,0,0,1
276,Somatic sex determination WP4814,0.5640451017109754,1.3845208845208845,0.7928058207904948,['AMH'],0.9999294775799197,0,0,1
277,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.5640451017109754,1.3845208845208845,0.7928058207904948,['MAPK3'],0.9999294775799197,0,0,1
278,The alternative pathway of fetal androgen synthesis WP4524,0.5640451017109754,1.3845208845208845,0.7928058207904948,['STAR'],0.9999294775799197,0,0,1
279,Non-small cell lung cancer WP4255,0.5657371085558175,0.9887533493160344,0.5632193990142575,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'E2F1', 'CYCS', 'BAX', 'HRAS', 'FHIT', 'MAPK3']",0.9999294775799197,0,0,10
280,Airway smooth muscle cell contraction WP4962,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['CALM1', 'CALM2']",0.9999294775799197,0,0,2
281,Cancer immunotherapy by PD-1 blockade WP4585,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['JUN', 'PDCD1LG2']",0.9999294775799197,0,0,2
282,Cell Differentiation - Index expanded WP2023,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['ID2', 'MEF2D']",0.9999294775799197,0,0,2
283,Ganglio Sphingolipid Metabolism WP1423,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['B3GALT1', 'FUT1']",0.9999294775799197,0,0,2
284,NOTCH1 regulation of endothelial cell calcification WP3413,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['JAG1', 'DLL3']",0.9999294775799197,0,0,2
285,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['LDHA', 'SLC2A3']",0.9999294775799197,0,0,2
286,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['FZD1', 'DKK3']",0.9999294775799197,0,0,2
287,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.5681183182865949,1.1075712881022615,0.6262491325519258,"['FN1', 'MAPK3']",0.9999294775799197,0,0,2
288,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5731072785626258,1.038305459911461,0.5780063308849359,"['H3F3B', 'SUV39H1', 'E2F1']",0.9999294775799197,0,0,3
289,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5731072785626258,1.038305459911461,0.5780063308849359,"['BAD', 'BAX', 'BBC3']",0.9999294775799197,0,0,3
290,Oxysterols derived from cholesterol WP4545,0.5782798211134842,1.0068002863278454,0.5514219070789628,"['CYP39A1', 'DBP', 'INSIG1', 'ACOT4']",0.9999294775799197,0,0,4
291,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5782798211134842,1.0068002863278454,0.5514219070789628,"['CDKN1B', 'BAD', 'FOXO4', 'HRAS']",0.9999294775799197,0,0,4
292,Neural Crest Cell Migration in Cancer WP4565,0.5833401095570423,0.9887810367869452,0.5329380328259925,"['ARF1', 'JUN', 'RAC1', 'FOS', 'EPHB3']",0.9999294775799197,0,0,5
293,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5882086422840512,0.9771080846131556,0.5185254259674621,"['JUN', 'PRKCQ', 'FOS', 'CALM1', 'CALM2', 'MAPK3']",0.9999294775799197,0,0,6
294,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6095335757948834,0.9771418651080698,0.48374506743946727,"['FSHR', 'RPS6', 'MAPK3']",0.9999294775799197,0,0,3
295,Signal Transduction of S1P Receptor WP26,0.6095335757948834,0.9771418651080698,0.48374506743946727,"['SMPD2', 'PLCB2', 'MAPK3']",0.9999294775799197,0,0,3
296,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6095335757948834,0.9771418651080698,0.48374506743946727,"['GSK3A', 'CALM1', 'CALM2']",0.9999294775799197,0,0,3
297,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6095765003444719,0.9629407737076344,0.47664684767284454,"['ACTA2', 'BAX', 'PRKCQ', 'NOS1']",0.9999294775799197,0,0,4
298,ATM Signaling Pathway WP2516,0.6111734498015562,0.9546002478819674,0.47002080212325636,"['CDKN1A', 'JUN', 'CRADD', 'H2AFX', 'RAD9A']",0.9999294775799197,0,0,5
299,Biomarkers for pyrimidine metabolism disorders WP4584,0.6133552325982803,1.0067935997139537,0.49213179871510776,"['RRM2', 'CKB']",0.9999294775799197,0,0,2
300,Fatty acid transporters WP5061,0.6133552325982803,1.0067935997139537,0.49213179871510776,"['FABP7', 'ACSL5']",0.9999294775799197,0,0,2
301,miRNA targets in ECM and membrane receptors WP2911,0.6133552325982803,1.0067935997139537,0.49213179871510776,"['LAMA4', 'FN1']",0.9999294775799197,0,0,2
302,Phytochemical activity on NRF2 transcriptional activation WP3,0.6133552325982803,1.0067935997139537,0.49213179871510776,"['CEBPB', 'KEAP1']",0.9999294775799197,0,0,2
303,Prolactin Signaling Pathway WP2037,0.6220431620196494,0.9400359300388156,0.4462781061906773,"['JUN', 'RPS6', 'RAC1', 'FOS', 'ELK1', 'CTSD', 'HRAS', 'YWHAG', 'MAPK3']",0.9999294775799197,0,0,9
304,Benzo(a)pyrene metabolism WP696,0.6307570078844508,1.1075184275184276,0.510382790631728,['CYP1B1'],0.9999294775799197,0,0,1
305,EDA signaling in hair follicle development WP3930,0.6307570078844508,1.1075184275184276,0.510382790631728,['SOSTDC1'],0.9999294775799197,0,0,1
306,Insulin signaling in adipocytes (diabetic condition) WP3635,0.6307570078844508,1.1075184275184276,0.510382790631728,['RPS6'],0.9999294775799197,0,0,1
307,Insulin signaling in adipocytes (normal condition) WP3634,0.6307570078844508,1.1075184275184276,0.510382790631728,['RPS6'],0.9999294775799197,0,0,1
308,LDLRAD4 and what we know about it WP4904,0.6307570078844508,1.1075184275184276,0.510382790631728,['PMEPA1'],0.9999294775799197,0,0,1
309,miRNA Biogenesis WP2338,0.6307570078844508,1.1075184275184276,0.510382790631728,['RAN'],0.9999294775799197,0,0,1
310,Nephrogenesis WP5052,0.6307570078844508,1.1075184275184276,0.510382790631728,['JAG1'],0.9999294775799197,0,0,1
311,Serotonin Transporter Activity WP1455,0.6307570078844508,1.1075184275184276,0.510382790631728,['NOS1'],0.9999294775799197,0,0,1
312,Vitamin B12 Disorders WP4271,0.6307570078844508,1.1075184275184276,0.510382790631728,['CUBN'],0.9999294775799197,0,0,1
313,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6378921404829073,0.9226981782373215,0.4148322465813886,"['CDKN1A', 'JUN', 'RRM2', 'RAC1', 'MAPK3']",0.9999294775799197,0,0,5
314,IL-6 signaling pathway WP364,0.6378921404829073,0.9226981782373215,0.4148322465813886,"['BAD', 'PRKCD', 'RAC1', 'MAPK3', 'NR2F6']",0.9999294775799197,0,0,5
315,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6378964873953479,0.9226600985221675,0.4148088390312714,"['FKBP1A', 'JUN', 'FOS', 'HRAS', 'LTBP1', 'MAPK3']",0.9999294775799197,0,0,6
316,Differentiation Pathway WP2848,0.643815892220482,0.9227742252828333,0.40633668659169564,"['FGF1', 'WNT2', 'FGF10']",0.9999294775799197,0,0,3
317,Fatty Acid Biosynthesis WP357,0.643815892220482,0.9227742252828333,0.40633668659169564,"['ACLY', 'ACSL5', 'ACACB']",0.9999294775799197,0,0,3
318,miRNA regulation of p53 pathway in prostate cancer WP3982,0.643815892220482,0.9227742252828333,0.40633668659169564,"['EI24', 'BAX', 'BBC3']",0.9999294775799197,0,0,3
319,Type II interferon signaling (IFNG) WP619,0.643815892220482,0.9227742252828333,0.40633668659169564,"['PRKCD', 'TAP1', 'IFIT2']",0.9999294775799197,0,0,3
320,Eicosanoid Synthesis WP167,0.654865491323044,0.9228121927236972,0.3906498601678867,"['PTGES2', 'PTGES']",0.9999294775799197,0,0,2
321,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.654865491323044,0.9228121927236972,0.3906498601678867,"['EGLN2', 'BCL2L2']",0.9999294775799197,0,0,2
322,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6613531575142256,0.8976434562641459,0.37114621997161823,"['ADCY10', 'CFL1', 'BANF1', 'HRAS', 'EMD', 'MAPK3']",0.9999294775799197,0,0,6
323,Modulators of TCR signaling and T cell activation WP5072,0.6613531575142256,0.8976434562641459,0.37114621997161823,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'PRKCQ', 'MEF2D']",0.9999294775799197,0,0,6
324,miRNA regulation of prostate cancer signaling pathways WP3981,0.6676904015999503,0.885748031496063,0.35778080780638843,"['AR', 'CDKN1A', 'CDKN1B', 'BAD']",0.9999294775799197,0,0,4
325,Estrogen signaling pathway WP712,0.6759101683627072,0.8741294949128847,0.34239223887988685,"['JUN', 'FOS', 'ELK1']",0.9999294775799197,0,0,3
326,Pancreatic adenocarcinoma pathway WP4263,0.6803094785783764,0.8951779230210603,0.3448292218429353,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'PRKCD', 'E2F1', 'PEBP1', 'BAX', 'RAC1', 'DUSP6', 'MAPK3']",0.9999294775799197,0,0,11
327,AGE/RAGE pathway WP2324,0.681527074273871,0.880527801424795,0.3376113542743923,"['JUN', 'PRKCD', 'CYCS', 'RAC1', 'FOXO4', 'MAPK3', 'SOD1']",0.9999294775799197,0,0,7
328,Cell Differentiation - Index WP2029,0.6872645492553235,0.9228501228501228,0.3461020019783038,['MEF2D'],0.9999294775799197,0,0,1
329,"Cerebral organic acidurias, including diseases WP4519",0.6872645492553235,0.9228501228501228,0.3461020019783038,['MDH2'],0.9999294775799197,0,0,1
330,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.6872645492553235,0.9228501228501228,0.3461020019783038,['DHCR24'],0.9999294775799197,0,0,1
331,Dual hijack model of Vif in HIV infection WP3300,0.6872645492553235,0.9228501228501228,0.3461020019783038,['ELOB'],0.9999294775799197,0,0,1
332,Estrogen metabolism WP697,0.6872645492553235,0.9228501228501228,0.3461020019783038,['CYP1B1'],0.9999294775799197,0,0,1
333,Inflammatory Response Pathway WP453,0.6872645492553235,0.9228501228501228,0.3461020019783038,['FN1'],0.9999294775799197,0,0,1
334,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.6872645492553235,0.9228501228501228,0.3461020019783038,['LPL'],0.9999294775799197,0,0,1
335,Methylation Pathways WP704,0.6872645492553235,0.9228501228501228,0.3461020019783038,['MAT2B'],0.9999294775799197,0,0,1
336,Osteoblast Signaling WP322,0.6872645492553235,0.9228501228501228,0.3461020019783038,['BGLAP'],0.9999294775799197,0,0,1
337,Sulfation Biotransformation Reaction WP692,0.6872645492553235,0.9228501228501228,0.3461020019783038,['SULT4A1'],0.9999294775799197,0,0,1
338,ERK Pathway in Huntington's Disease WP3853,0.6927301961101903,0.8517510021934801,0.31269029916701996,"['ELK1', 'HRAS']",0.9999294775799197,0,0,2
339,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6927301961101903,0.8517510021934801,0.31269029916701996,"['ABCB1', 'PPARG']",0.9999294775799197,0,0,2
340,MAPK Cascade WP422,0.6944180322406595,0.8516050878255602,0.31056432097263714,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,4
341,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6992920391021231,0.8680821441002436,0.31050154894206866,"['FZD1', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'CSNK2B', 'WNT7A', 'WNT2']",0.9999294775799197,0,0,8
342,Hepatitis B infection WP4666,0.6993769255750427,0.8940894089408941,0.3196954788440109,"['JUN', 'EGR2', 'CDKN1A', 'EGR3', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'BAD', 'FOS', 'ELK1', 'CREB3', 'IRAK1', 'CYCS', 'BAX', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,16
343,3q29 copy number variation syndrome WP4906,0.7016572542890306,0.8608838508296369,0.30501996030322953,"['JUN', 'NCBP2', 'DYNLT3', 'MAD2L1BP', 'FBXO45', 'DYNLL1', 'DYNLL2']",0.9999294775799197,0,0,7
344,16p11.2 distal deletion syndrome WP4950,0.7058125713907041,0.8303492375799312,0.28929828808500757,"['PLN', 'CD81', 'TUFM']",0.9999294775799197,0,0,3
345,Cannabinoid receptor signaling WP3869,0.7058125713907041,0.8303492375799312,0.28929828808500757,"['ADORA2A', 'PRKAR1A', 'MAPK3']",0.9999294775799197,0,0,3
346,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7058125713907041,0.8303492375799312,0.28929828808500757,"['LPL', 'FOXO4', 'RAC1']",0.9999294775799197,0,0,3
347,Signal transduction through IL1R WP4496,0.7058125713907041,0.8303492375799312,0.28929828808500757,"['JUN', 'IRAK1', 'TOLLIP']",0.9999294775799197,0,0,3
348,Wnt signaling in kidney disease WP4150,0.7058125713907041,0.8303492375799312,0.28929828808500757,"['FZD1', 'WNT7A', 'WNT2']",0.9999294775799197,0,0,3
349,Target Of Rapamycin (TOR) Signaling WP1471,0.7195713414254433,0.8199912510936133,0.2698587955263665,"['FKBP1A', 'RRAGA', 'RRAGC', 'RAC1']",0.9999294775799197,0,0,4
350,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.727092821660038,0.7908414103104369,0.25204205264862234,"['PRXL2B', 'PTGES']",0.9999294775799197,0,0,2
351,Microglia Pathogen Phagocytosis Pathway WP3937,0.727092821660038,0.7908414103104369,0.25204205264862234,"['VAV3', 'RAC1']",0.9999294775799197,0,0,2
352,One-carbon metabolism WP241,0.727092821660038,0.7908414103104369,0.25204205264862234,"['AHCY', 'MAT2B']",0.9999294775799197,0,0,2
353,Proteoglycan biosynthesis WP4784,0.727092821660038,0.7908414103104369,0.25204205264862234,"['B3GALT6', 'B4GALT7']",0.9999294775799197,0,0,2
354,Lung fibrosis WP3624,0.7335518102767835,0.7907385285644016,0.24501590744182253,"['FGF7', 'CEBPB', 'FGF1']",0.9999294775799197,0,0,3
355,Neovascularisation processes WP4331,0.7335518102767835,0.7907385285644016,0.24501590744182253,"['JAG1', 'NOTCH4', 'MAPK3']",0.9999294775799197,0,0,3
356,ATR Signaling WP3875,0.7351279507399276,0.790944190944191,0.24338200036961413,['RAD9A'],0.9999294775799197,0,0,1
357,Biomarkers for urea cycle disorders WP4583,0.7351279507399276,0.790944190944191,0.24338200036961413,['GOT1'],0.9999294775799197,0,0,1
358,Canonical NF-KB pathway WP4562,0.7351279507399276,0.790944190944191,0.24338200036961413,['NFKBIE'],0.9999294775799197,0,0,1
359,"Degradation pathway of sphingolipids, including diseases WP4153",0.7351279507399276,0.790944190944191,0.24338200036961413,['NEU1'],0.9999294775799197,0,0,1
360,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7351279507399276,0.790944190944191,0.24338200036961413,['ELOB'],0.9999294775799197,0,0,1
361,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.7351279507399276,0.790944190944191,0.24338200036961413,['IRAK1'],0.9999294775799197,0,0,1
362,Iron metabolism in placenta WP2007,0.7351279507399276,0.790944190944191,0.24338200036961413,['FTH1'],0.9999294775799197,0,0,1
363,Leptin and adiponectin WP3934,0.7351279507399276,0.790944190944191,0.24338200036961413,['LEPR'],0.9999294775799197,0,0,1
364,Mitochondrial CII Assembly WP4920,0.7351279507399276,0.790944190944191,0.24338200036961413,['SDHAF1'],0.9999294775799197,0,0,1
365,Vitamin D-sensitive calcium signaling in depression WP4698,0.7431581972877637,0.7906355455568054,0.2346972679615022,"['CHRM1', 'CALB1', 'GPX4', 'KCNQ3']",0.9999294775799197,0,0,4
366,Wnt signaling WP428,0.7449893760583202,0.8381943821233061,0.24675212226578827,"['FZD1', 'FRAT1', 'JUN', 'FRAT2', 'SFRP2', 'CSNK2B', 'WNT7A', 'RAC1', 'WNT2', 'PLCB2']",0.9999294775799197,0,0,10
367,Kit receptor signaling pathway WP304,0.7452379569088325,0.8097801273579238,0.23811722822182013,"['BAD', 'RPS6', 'MITF', 'FOS', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,6
368,Focal Adhesion WP306,0.7498523548342895,0.870750531183602,0.250670750416071,"['VAV3', 'SHC4', 'JUN', 'CAV3', 'ITGA4', 'CAV2', 'BAD', 'LAMA4', 'LAMA3', 'FN1', 'ELK1', 'ACTB', 'MYL12B', 'ACTG1', 'PPP1CC', 'PDGFD', 'ITGA10', 'RAC1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,20
369,MET in type 1 papillary renal cell carcinoma WP4205,0.7568765136482004,0.8068629866929522,0.22475585223837688,"['CDKN1A', 'JUN', 'BAD', 'RPL11', 'RAC1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,7
370,Ebstein-Barr virus LMP1 signaling WP262,0.7581382525166048,0.7380530973451327,0.20435916696400405,"['HSP90AA1', 'IRAK1']",0.9999294775799197,0,0,2
371,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7581382525166048,0.7380530973451327,0.20435916696400405,"['HRAS', 'MAPK3']",0.9999294775799197,0,0,2
372,Purine metabolism and related disorders WP4224,0.7581382525166048,0.7380530973451327,0.20435916696400405,"['PRPS1', 'APRT']",0.9999294775799197,0,0,2
373,IL17 signaling pathway WP2112,0.759182311404586,0.7547287930957385,0.2079378437502466,"['CEBPB', 'IL17RE', 'MAPK3']",0.9999294775799197,0,0,3
374,EGF/EGFR signaling pathway WP437,0.7605822929699841,0.8638702876984127,0.23641621449475358,"['VAV3', 'NDUFA13', 'JUN', 'JUND', 'CAV2', 'PRKCD', 'PEBP1', 'FOXO4', 'FOS', 'ELK1', 'EPN1', 'CFL1', 'STMN1', 'E2F1', 'FOSB', 'RAC1', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9999294775799197,0,0,20
375,Amino Acid metabolism WP3925,0.7632721030233253,0.8161702265319821,0.2204807870911563,"['ACLY', 'LDHA', 'PKM', 'OAT', 'TDO2', 'GOT1', 'MDH2', 'ALDH1A1', 'ODC1']",0.9999294775799197,0,0,9
376,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7652020437823266,0.7633043714363291,0.2042719821715456,"['JUN', 'DDIT3', 'FOS', 'MAPK3']",0.9999294775799197,0,0,4
377,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7652020437823266,0.7633043714363291,0.2042719821715456,"['ACTA2', 'ACTC1', 'ACTB', 'ACTG1']",0.9999294775799197,0,0,4
378,Cytosolic DNA-sensing pathway WP4655,0.7728905376604537,0.7685048416215329,0.19798056315968968,"['IL18', 'POLR2E', 'POLR3H', 'POLR2K', 'POLR2L']",0.9999294775799197,0,0,5
379,Biotin Metabolism (including IEMs) WP5031,0.7756689816927825,0.692014742014742,0.17579210339964899,['ACACB'],0.9999294775799197,0,0,1
380,Cancer immunotherapy by CTLA4 blockade WP4582,0.7756689816927825,0.692014742014742,0.17579210339964899,['PPP2CA'],0.9999294775799197,0,0,1
381,Glutathione metabolism WP100,0.7756689816927825,0.692014742014742,0.17579210339964899,['GPX4'],0.9999294775799197,0,0,1
382,Serotonin and anxiety-related events WP3944,0.7756689816927825,0.692014742014742,0.17579210339964899,['FOS'],0.9999294775799197,0,0,1
383,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7811016202482127,0.7719784625959446,0.1907172962080403,"['CDKN2A', 'H2AFX', 'ACTL6A', 'E2F1', 'BAX', 'RAD9A']",0.9999294775799197,0,0,6
384,T-cell receptor (TCR) signaling pathway WP69,0.7829874919631121,0.7902225979149056,0.19331891655520347,"['VAV3', 'JUN', 'CD83', 'PRKCD', 'PRKCQ', 'FOS', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,8
385,Phosphoinositides metabolism WP4971,0.7857391615099211,0.7377952755905511,0.17790486786614781,"['PIP4P1', 'PIK3C2G', 'PIP4K2C', 'PLCB2']",0.9999294775799197,0,0,4
386,Immune response to tuberculosis WP4197,0.7860767692582714,0.6918633235004916,0.16653206964759543,"['TAP1', 'IFIT1']",0.9999294775799197,0,0,2
387,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7860767692582714,0.6918633235004916,0.16653206964759543,"['B3GALNT1', 'B3GALT1']",0.9999294775799197,0,0,2
388,NAD+ biosynthetic pathways WP3645,0.7860767692582714,0.6918633235004916,0.16653206964759543,"['TDO2', 'ACMSD']",0.9999294775799197,0,0,2
389,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7860767692582714,0.6918633235004916,0.16653206964759543,"['MDH2', 'IDH3B']",0.9999294775799197,0,0,2
390,Toll-like Receptor Signaling related to MyD88 WP3858,0.7860767692582714,0.6918633235004916,0.16653206964759543,"['IRAK1', 'TOLLIP']",0.9999294775799197,0,0,2
391,Pathways Regulating Hippo Signaling WP4540,0.7919642692336237,0.7901191063499894,0.18428659244993606,"['PRKCH', 'PRKD3', 'PRKAR1A', 'FLT3', 'PRKCD', 'PRKCQ', 'RAC1', 'PLCB2', 'CDH7']",0.9999294775799197,0,0,9
392,GABA receptor Signaling WP4159,0.8044284405360395,0.691711756025578,0.1505325711294808,"['GABBR1', 'GABRD', 'AP2M1']",0.9999294775799197,0,0,3
393,Intraflagellar transport proteins binding to dynein WP4532,0.8044284405360395,0.691711756025578,0.1505325711294808,"['DYNLT3', 'DYNLL1', 'DYNLL2']",0.9999294775799197,0,0,3
394,B Cell Receptor Signaling Pathway WP23,0.8053136935447038,0.7777041193882586,0.16839113705020667,"['JUN', 'GSK3A', 'CD81', 'PRKCD', 'RAC1', 'ELK1', 'ILF2', 'HRAS', 'MEF2D']",0.9999294775799197,0,0,9
395,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.808209215968837,0.7279276477752727,0.15500078110734686,"['EIF4A2', 'PRKCD', 'RPS6', 'PIM2', 'MAPK3']",0.9999294775799197,0,0,5
396,Alanine and aspartate metabolism WP106,0.8100073851559728,0.6150696150696151,0.1296024957611883,['GOT1'],0.9999294775799197,0,0,1
397,Hedgehog Signaling Pathway Netpath WP47,0.8100073851559728,0.6150696150696151,0.1296024957611883,['SAP18'],0.9999294775799197,0,0,1
398,Nanoparticle triggered regulated necrosis WP2513,0.8100073851559728,0.6150696150696151,0.1296024957611883,['FTL'],0.9999294775799197,0,0,1
399,Osteoclast Signaling WP12,0.8100073851559728,0.6150696150696151,0.1296024957611883,['ATP6V1G1'],0.9999294775799197,0,0,1
400,Osteopontin Signaling WP1434,0.8100073851559728,0.6150696150696151,0.1296024957611883,['MAPK3'],0.9999294775799197,0,0,1
401,TCA cycle in senescence WP5050,0.8100073851559728,0.6150696150696151,0.1296024957611883,['GOT1'],0.9999294775799197,0,0,1
402,Angiogenesis WP1539,0.811131960804215,0.6511076406963966,0.13629279722924398,"['TIMP2', 'TIMP3']",0.9999294775799197,0,0,2
403,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.811131960804215,0.6511076406963966,0.13629279722924398,"['FZD1', 'FGF1']",0.9999294775799197,0,0,2
404,Trans-sulfuration and one-carbon metabolism WP2525,0.811131960804215,0.6511076406963966,0.13629279722924398,"['AHCY', 'MAT2B']",0.9999294775799197,0,0,2
405,Ciliary landscape WP4352,0.8137536590598275,0.8449048873280656,0.17413286015261972,"['DOCK5', 'VPS4A', 'COPS7A', 'PSMD8', 'EXOSC4', 'ARHGDIA', 'NEFL', 'NEFM', 'TMED1', 'RAC1', 'DCAF11', 'NINL', 'EXOC8', 'RHBDD2', 'DYNLT3', 'DYNLL1', 'DYNLL2', 'LSM4', 'TTC30A', 'GID8', 'MCM3', 'CD2BP2', 'MCM4', 'CALM1', 'COPS8', 'CALM2']",0.9999294775799197,0,0,26
406,Head and Neck Squamous Cell Carcinoma WP4674,0.8184735558133491,0.7445312203813929,0.14914016893690968,"['FKBP1A', 'CDKN1A', 'CDKN2A', 'RPS6', 'E2F1', 'KEAP1', 'HRAS']",0.9999294775799197,0,0,7
407,Nucleotide Excision Repair WP4753,0.8241546232647193,0.7091997121539219,0.13715717976704633,"['POLE4', 'CETN2', 'RPA3', 'POLD2', 'POLE3']",0.9999294775799197,0,0,5
408,RANKL/RANK signaling pathway WP2018,0.8241546232647193,0.7091997121539219,0.13715717976704633,"['JUN', 'MITF', 'RAC1', 'FOS', 'MAPK3']",0.9999294775799197,0,0,5
409,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8241546232647193,0.7091997121539219,0.13715717976704633,"['IRAK1', 'TOLLIP', 'FOS', 'ELK1', 'MAPK3']",0.9999294775799197,0,0,5
410,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8242282319980342,0.7498412061645439,0.14495015904535202,"['CREB3', 'THRA', 'BAD', 'RPS6', 'PRKCQ', 'PPARG', 'HRAS', 'TSHR']",0.9999294775799197,0,0,8
411,Autophagy WP4923,0.8242319254680432,0.6639842597147073,0.1283503656347436,"['MAP1LC3B', 'ATG101', 'ATG9A']",0.9999294775799197,0,0,3
412,Tumor suppressor activity of SMARCB1 WP4204,0.8242319254680432,0.6639842597147073,0.1283503656347436,"['H3F3B', 'CDKN2A', 'ACTL6A']",0.9999294775799197,0,0,3
413,1q21.1 copy number variation syndrome WP4905,0.8335317383485876,0.6148803670927565,0.11195956877652101,"['PYGO2', 'ACP6']",0.9999294775799197,0,0,2
414,EPO Receptor Signaling WP581,0.8335317383485876,0.6148803670927565,0.11195956877652101,"['EPOR', 'MAPK3']",0.9999294775799197,0,0,2
415,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8335317383485876,0.6148803670927565,0.11195956877652101,"['CEBPA', 'CEBPB']",0.9999294775799197,0,0,2
416,NRF2-ARE regulation WP4357,0.8335317383485876,0.6148803670927565,0.11195956877652101,"['CEBPB', 'KEAP1']",0.9999294775799197,0,0,2
417,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8335317383485876,0.6148803670927565,0.11195956877652101,"['GNA15', 'PLCB2']",0.9999294775799197,0,0,2
418,Interleukin-11 Signaling Pathway WP2332,0.8388147573445802,0.6705440229062276,0.11785842949108387,"['BGLAP', 'RPS6', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,4
419,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.839091743515913,0.5535135135135135,0.09710577046543017,['EXPH5'],0.9999294775799197,0,0,1
420,GPR40 Pathway WP3958,0.839091743515913,0.5535135135135135,0.09710577046543017,['PLCB2'],0.9999294775799197,0,0,1
421,Homologous recombination WP186,0.839091743515913,0.5535135135135135,0.09710577046543017,['POLD2'],0.9999294775799197,0,0,1
422,Leptin Insulin Overlap WP3935,0.839091743515913,0.5535135135135135,0.09710577046543017,['LEPR'],0.9999294775799197,0,0,1
423,Mammalian disorder of sexual development WP4842,0.839091743515913,0.5535135135135135,0.09710577046543017,['AMH'],0.9999294775799197,0,0,1
424,NO metabolism in cystic fibrosis WP4947,0.839091743515913,0.5535135135135135,0.09710577046543017,['NOS1'],0.9999294775799197,0,0,1
425,Regulation of Actin Cytoskeleton WP51,0.8460074927415069,0.7819779111779149,0.1307678692190716,"['CHRM1', 'FN1', 'BRK1', 'PIK3C2G', 'FGF1', 'ACTB', 'ACTG1', 'FGF7', 'CFL2', 'TMSB4X', 'CFL1', 'PIP4K2C', 'RAC1', 'FGF10', 'MAPK3']",0.9999294775799197,0,0,15
426,Fatty acid beta-oxidation WP143,0.8587250442208949,0.6146909329398262,0.09362142239863849,"['TPI1', 'LPL', 'ACSL5']",0.9999294775799197,0,0,3
427,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.863725630682655,0.5031494304221577,0.07371145077263765,['CCK'],0.9999294775799197,0,0,1
428,Serotonin and anxiety WP3947,0.863725630682655,0.5031494304221577,0.07371145077263765,['FOS'],0.9999294775799197,0,0,1
429,Cardiac Hypertrophic Response WP2795,0.8656237760552838,0.6583667440388268,0.09500554949956908,"['NRG1', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.9999294775799197,0,0,5
430,ESC Pluripotency Pathways WP3931,0.8661955389741461,0.7272561957707695,0.10446642557575962,"['FZD1', 'FGF7', 'JUN', 'WNT7A', 'FOS', 'FGF1', 'ELK1', 'WNT2', 'HRAS', 'FGF10']",0.9999294775799197,0,0,10
431,Regulation of Microtubule Cytoskeleton WP2038,0.8676982511699183,0.6321147356580428,0.08970419965270189,"['PARD6A', 'CFL2', 'STMN1', 'RAC1']",0.9999294775799197,0,0,4
432,TGF-beta Signaling Pathway WP366,0.8697071334527252,0.7482390014829461,0.10445323096992838,"['KLF10', 'JUN', 'CDKN1A', 'JUND', 'CITED1', 'FN1', 'NEDD9', 'FOS', 'PARD6A', 'STRAP', 'FOSB', 'RAC1', 'SKP1']",0.9999294775799197,0,0,13
433,Gastric Cancer Network 2 WP2363,0.8712609024312122,0.5532940019665683,0.07625155082867892,"['S100A6', 'CACYBP']",0.9999294775799197,0,0,2
434,Regulation of toll-like receptor signaling pathway WP1449,0.8721766275523861,0.7106631897949115,0.09719265798576282,"['JUN', 'IRAK1', 'TOLLIP', 'PELI3', 'PELI2', 'RAC1', 'FOS', 'TMED7', 'MAPK3']",0.9999294775799197,0,0,9
435,Toll-like Receptor Signaling Pathway WP75,0.8768052755460196,0.663487684729064,0.0872289554704323,"['JUN', 'IRAK1', 'TOLLIP', 'RAC1', 'FOS', 'MAPK3']",0.9999294775799197,0,0,6
436,IL-1 signaling pathway WP195,0.8774784961478754,0.6429986373993793,0.08404174143784972,"['JUN', 'IRAK1', 'TOLLIP', 'PELI2', 'MAPK3']",0.9999294775799197,0,0,5
437,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8803921789967322,0.614501312335958,0.07827997816275367,"['MAP1LC3A', 'ATG101', 'GTPBP2', 'FTL']",0.9999294775799197,0,0,4
438,"GPCRs, Class B Secretin-like WP334",0.8845897703374707,0.4611793611793612,0.056555014348217456,['ADGRG2'],0.9999294775799197,0,0,1
439,IL-9 signaling pathway WP22,0.8845897703374707,0.4611793611793612,0.056555014348217456,['MAPK3'],0.9999294775799197,0,0,1
440,Ethanol effects on histone modifications WP3996,0.8870178430953235,0.5268998454839163,0.06317011765723715,"['AHCY', 'ALDH1A1']",0.9999294775799197,0,0,2
441,Hematopoietic Stem Cell Differentiation WP2849,0.8870178430953235,0.5268998454839163,0.06317011765723715,"['FOSB', 'FOS']",0.9999294775799197,0,0,2
442,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8871318312809332,0.5721966857201011,0.06852723734212479,"['MAP1LC3A', 'IGFBP5', 'TNFSF9']",0.9999294775799197,0,0,3
443,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8871318312809332,0.5721966857201011,0.06852723734212479,"['JUN', 'RAC1', 'MAPK3']",0.9999294775799197,0,0,3
444,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8881860959770834,0.6802609619177666,0.08066125677093618,"['SHC4', 'BAD', 'PDGFD', 'RPS6', 'BAX', 'NRG1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,8
445,ATM Signaling Network in Development and Disease  WP3878,0.8920139484549036,0.5978399659502022,0.068317270874909,"['ATMIN', 'H2AFX', 'HSPB1', 'CDK5R1']",0.9999294775799197,0,0,4
446,PPAR signaling pathway WP3942,0.8920139484549036,0.5978399659502022,0.068317270874909,"['FABP7', 'ACSL5', 'LPL', 'PPARG']",0.9999294775799197,0,0,4
447,ErbB signaling pathway WP673,0.8978479025795154,0.6812753850416635,0.07341055561356565,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'BAD', 'NRG1', 'ELK1', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,9
448,Allograft Rejection WP2328,0.8993247752323281,0.5530742744712248,0.058687290320665456,"['ABCB1', 'HLA-C', 'HLA-DQB1']",0.9999294775799197,0,0,3
449,Notch Signaling WP268,0.8993247752323281,0.5530742744712248,0.058687290320665456,"['JAG1', 'NOTCH4', 'DLL3']",0.9999294775799197,0,0,3
450,Type 2 papillary renal cell carcinoma WP4241,0.8993247752323281,0.5530742744712248,0.058687290320665456,"['CDKN1A', 'EGLN2', 'ELOB']",0.9999294775799197,0,0,3
451,Fluoropyrimidine Activity WP1601,0.9009692575519984,0.5029051577724144,0.05244503304657724,"['RRM2', 'UCK1']",0.9999294775799197,0,0,2
452,Sphingolipid pathway WP1422,0.9009692575519984,0.5029051577724144,0.05244503304657724,"['PPP2CA', 'SERINC1']",0.9999294775799197,0,0,2
453,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9022608091257625,0.42566622566622564,0.04378047593284115,['LTB4R'],0.9999294775799197,0,0,1
454,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9022608091257625,0.42566622566622564,0.04378047593284115,['FRAT1'],0.9999294775799197,0,0,1
455,Pyrimidine metabolism and related diseases WP4225,0.9022608091257625,0.42566622566622564,0.04378047593284115,['RRM2'],0.9999294775799197,0,0,1
456,Riboflavin and CoQ disorders WP5037,0.9022608091257625,0.42566622566622564,0.04378047593284115,['RFK'],0.9999294775799197,0,0,1
457,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9022608091257625,0.42566622566622564,0.04378047593284115,['NFKBIE'],0.9999294775799197,0,0,1
458,DNA Repair Pathways Full Network WP4946,0.9057471752825162,0.7108793430010327,0.07037354880214186,"['FEN1', 'CENPX', 'CETN2', 'H2AFX', 'APEX2', 'FANCF', 'POLE4', 'NEIL2', 'RPA3', 'APEX1', 'POLD2', 'POLE3', 'USP1']",0.9999294775799197,0,0,13
459,MAPK Signaling Pathway WP382,0.9103260535400515,0.7654190464151507,0.07191298936931759,"['DUSP4', 'HSPA8', 'JUN', 'DUSP2', 'JUND', 'DUSP3', 'PRKCD', 'HSPB1', 'FOS', 'FGF1', 'ELK1', 'DUSP6', 'DUSP7', 'NR4A1', 'FGF7', 'CACNB3', 'DDIT3', 'STMN1', 'RAC1', 'HRAS', 'HSPA1B', 'HSPA1A', 'FGF10', 'MAPK3']",0.9999294775799197,0,0,24
460,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9123917849649142,0.6341733390428944,0.058144685094723876,"['FZD1', 'NRG1', 'RAC1', 'CALM1', 'PLCB2', 'CALM2', 'MAPK3']",0.9999294775799197,0,0,7
461,Resistin as a regulator of inflammation WP4481,0.9132985145289262,0.4809969646445214,0.04362281325903939,"['PLCB2', 'MAPK3']",0.9999294775799197,0,0,2
462,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.917227222670362,0.39522639522639524,0.034147579616733474,['MAPK3'],0.9999294775799197,0,0,1
463,Glycosaminoglycan degradation WP4815,0.917227222670362,0.39522639522639524,0.034147579616733474,['IDS'],0.9999294775799197,0,0,1
464,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.917227222670362,0.39522639522639524,0.034147579616733474,['ACLY'],0.9999294775799197,0,0,1
465,Netrin-UNC5B signaling pathway WP4747,0.920207555833703,0.5184149040826365,0.043109325428722665,"['JUN', 'RAC1', 'MAPK3']",0.9999294775799197,0,0,3
466,Lipid Metabolism Pathway WP3965,0.9241751605872883,0.4609144542772861,0.036344790547098556,"['ACLY', 'PRKAR1A']",0.9999294775799197,0,0,2
467,Nanoparticle-mediated activation of receptor signaling WP2643,0.9241751605872883,0.4609144542772861,0.036344790547098556,"['FN1', 'HRAS']",0.9999294775799197,0,0,2
468,Wnt Signaling Pathway WP363,0.929145792957319,0.5393220664490109,0.039634572163867225,"['GSK3A', 'FRAT1', 'PPARG', 'RAC1']",0.9999294775799197,0,0,4
469,Kallmann's Syndrome WP5074,0.9299027915683247,0.3688452088452088,0.02680590798726738,['PRKCQ'],0.9999294775799197,0,0,1
470,Statin inhibition of cholesterol production WP430,0.9299027915683247,0.3688452088452088,0.02680590798726738,['LPL'],0.9999294775799197,0,0,1
471,Neural Crest Differentiation WP2064,0.9313801815126344,0.5639626603965072,0.040090823544620034,"['NOTCH4', 'MITF', 'CDH7', 'RHOB', 'DLL3']",0.9999294775799197,0,0,5
472,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9337548564785061,0.4424385447394297,0.03032533138805968,"['JUN', 'FOS']",0.9999294775799197,0,0,2
473,Integrin-mediated Cell Adhesion WP185,0.937042949990948,0.613740959894806,0.039909217871246294,"['VAV3', 'CAPNS1', 'CAV3', 'ITGA4', 'CAV2', 'ITGA10', 'RAC1', 'HRAS']",0.9999294775799197,0,0,8
474,One-carbon metabolism and related pathways WP3940,0.9370566683359386,0.48783310668094093,0.03171477181666435,"['GPX4', 'SOD2', 'SOD1']",0.9999294775799197,0,0,3
475,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9405529248270873,0.571564464073382,0.0350296763579991,"['ACLY', 'GSK3A', 'RBP4', 'INSIG1', 'LPL', 'PPARG']",0.9999294775799197,0,0,6
476,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.940638018543778,0.34576167076167075,0.02115953921823006,['FLT3'],0.9999294775799197,0,0,1
477,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9421796562240139,0.4253838590121776,0.025335566886225635,"['HEXIM1', 'SUPT4H1']",0.9999294775799197,0,0,2
478,Insulin Signaling WP481,0.9481584856899278,0.678994668697639,0.036145338541281796,"['EGR1', 'XBP1', 'JUN', 'ARF1', 'GSK3A', 'PRKCH', 'PRKCD', 'PIK3C2G', 'FOS', 'ELK1', 'EHD1', 'PRKCQ', 'RAC1', 'HRAS', 'ARF6', 'MAPK3']",0.9999294775799197,0,0,16
479,AMP-activated protein kinase (AMPK) signaling WP1403,0.9494038087943591,0.5312843237510889,0.027584845825380698,"['CCNA1', 'CDKN1A', 'LEPR', 'EEF2', 'ACACB']",0.9999294775799197,0,0,5
480,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9495785255556343,0.409592483338796,0.021191106848462454,"['RPS6', 'MAPK3']",0.9999294775799197,0,0,2
481,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.949729801316407,0.32539384304090185,0.016783083755245235,['MAP1LC3A'],0.9999294775799197,0,0,1
482,miRNAs involvement in the immune response in sepsis WP4329,0.949729801316407,0.32539384304090185,0.016783083755245235,['IRAK1'],0.9999294775799197,0,0,1
483,Histone Modifications WP2369,0.9562510471972073,0.4481594235652278,0.02004832161384648,"['SET', 'H3F3B', 'SUV39H1']",0.9999294775799197,0,0,3
484,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9574296272104341,0.3072891072891073,0.013368015554270557,['FLT3'],0.9999294775799197,0,0,1
485,TLR4 Signaling and Tolerance WP3851,0.9574296272104341,0.3072891072891073,0.013368015554270557,['IRAK1'],0.9999294775799197,0,0,1
486,Thermogenesis WP4321,0.9581350013437777,0.5914793149622948,0.025295553922222165,"['ADCY10', 'CREB3', 'RPS6', 'ACTL6A', 'ACSL5', 'PPARG', 'HRAS', 'ACTB', 'ACTG1']",0.9999294775799197,0,0,9
487,Ras signaling WP4223,0.9602254362620094,0.6514472059127195,0.026440413246888395,"['SHC4', 'FLT3', 'BAD', 'FOXO4', 'ELK1', 'ETS2', 'GNG10', 'GNG3', 'CALM3', 'RAC1', 'CALM1', 'CALM2', 'HRAS', 'ARF6', 'MAPK3']",0.9999294775799197,0,0,15
488,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9639505160588884,0.29109013319539634,0.010687466684160544,['IRAK1'],0.9999294775799197,0,0,1
489,Genes controlling nephrogenesis WP4823,0.9639505160588884,0.29109013319539634,0.010687466684160544,['ETV4'],0.9999294775799197,0,0,1
490,SARS-CoV-2 mitochondrial interactions WP5038,0.9639505160588884,0.29109013319539634,0.010687466684160544,['PHB'],0.9999294775799197,0,0,1
491,Disruption of postsynaptic signaling by CNV WP4875,0.966727773742898,0.3685349065880039,0.012470609270814073,"['YWHAG', 'MAPK3']",0.9999294775799197,0,0,2
492,Hedgehog Signaling Pathway WP4249,0.966727773742898,0.3685349065880039,0.012470609270814073,"['EVC', 'HHIP']",0.9999294775799197,0,0,2
493,MECP2 and Associated Rett Syndrome WP3584,0.9667502626278017,0.4931595976647675,0.016676229686583745,"['GPRIN1', 'RPS6', 'E2F1', 'TAP1', 'FKBP5']",0.9999294775799197,0,0,5
494,Hippo-Merlin Signaling Dysregulation WP4541,0.9678381023854844,0.5367586660095285,0.01754688517544557,"['PPP1CC', 'ITGA4', 'PRKAR1A', 'FLT3', 'ITGA10', 'HRAS', 'CDH7']",0.9999294775799197,0,0,7
495,Integrated breast cancer pathway WP1984,0.968064601865115,0.6181243288390407,0.02006212537105032,"['PLK3', 'JUN', 'GSK3A', 'BAD', 'ODC1', 'PHB', 'JAKMIP1', 'FOSL2', 'AR', 'E2F1', 'BAX', 'RAC1', 'FAU']",0.9999294775799197,0,0,13
496,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9694729014272192,0.2765110565110565,0.008572604752941693,['HRAS'],0.9999294775799197,0,0,1
497,Glycerolipids and Glycerophospholipids WP4722,0.9694729014272192,0.2765110565110565,0.008572604752941693,['CDIPT'],0.9999294775799197,0,0,1
498,Sphingolipid Metabolism (general overview) WP4725,0.9694729014272192,0.2765110565110565,0.008572604752941693,['SMPD1'],0.9999294775799197,0,0,1
499,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.9694729014272192,0.2765110565110565,0.008572604752941693,['FZD1'],0.9999294775799197,0,0,1
500,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9710763169387508,0.3566149649506772,0.01046672680286318,"['SLC12A5', 'GABRD']",0.9999294775799197,0,0,2
501,MTHFR deficiency WP4288,0.9741496135632276,0.2633204633204633,0.006896462938619408,['CYCS'],0.9999294775799197,0,0,1
502,Nanoparticle triggered autophagic cell death WP2509,0.9741496135632276,0.2633204633204633,0.006896462938619408,['MAP1LC3A'],0.9999294775799197,0,0,1
503,Sphingolipid Metabolism (integrated pathway) WP4726,0.9741496135632276,0.2633204633204633,0.006896462938619408,['SMPD1'],0.9999294775799197,0,0,1
504,Nephrotic syndrome WP4758,0.9748737442277242,0.3454400196656834,0.008790519083415351,"['CUBN', 'ARHGDIA']",0.9999294775799197,0,0,2
505,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9765775624896647,0.39463143840910686,0.009353200268870637,"['GRIN3A', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,3
506,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9810747568031293,0.3250621782636358,0.006210838745382506,"['CXCL17', 'IFIT2']",0.9999294775799197,0,0,2
507,p53 transcriptional gene network WP4963,0.9818599272659485,0.3766265706747753,0.00689475991064691,"['CDKN1A', 'BAX', 'BBC3']",0.9999294775799197,0,0,3
508,Chemokine signaling pathway WP3929,0.9857989246882753,0.5169893931919092,0.007394434932135152,"['SHC4', 'VAV3', 'GNG10', 'GNG3', 'PRKCD', 'RAC1', 'HRAS', 'PLCB2', 'MAPK3']",0.9999294775799197,0,0,9
509,Glycerophospholipid Biosynthetic Pathway WP2533,0.9867093035218337,0.22111056511056512,0.002958416960334427,['CDIPT'],0.9999294775799197,0,0,1
510,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9877021447785889,0.35249238626492657,0.004361775889723432,"['CDKN1A', 'CDKN1B', 'JAG1']",0.9999294775799197,0,0,3
511,Mesodermal commitment pathway WP2857,0.9881016476586638,0.49020381328073637,0.00586759468222883,"['VAV3', 'PPP2CA', 'ARL4A', 'PRKAR1A', 'TRIM5', 'BHLHE40', 'RPL38', 'AMH']",0.9999294775799197,0,0,8
512,DNA IR-damage and cellular response via ATR WP4016,0.9890170285067746,0.41806544022201336,0.004617001678562313,"['FEN1', 'H2AFX', 'E2F1', 'USP1', 'RAD9A']",0.9999294775799197,0,0,5
513,Endoderm differentiation WP2853,0.9902515064152739,0.47946145270559987,0.004696958409943654,"['VAV3', 'DUSP4', 'MAD2L2', 'DUSP5', 'DUSP2', 'TRIM5', 'TCEAL2', 'NME1']",0.9999294775799197,0,0,8
514,Splicing factor NOVA regulated synaptic proteins WP4148,0.9907735188992511,0.28326147795174345,0.002625638085678692,"['CAV2', 'NCDN']",0.9999294775799197,0,0,2
515,Pathways affected in adenoid cystic carcinoma WP3651,0.9917112167491452,0.3312543039842597,0.0027571376360495375,"['MORF4L1', 'CEBPA', 'HRAS']",0.9999294775799197,0,0,3
516,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9917112167491452,0.3312543039842597,0.0027571376360495375,"['DUSP2', 'STMN1', 'MAPK3']",0.9999294775799197,0,0,3
517,Energy Metabolism WP1541,0.9920203195659123,0.2761553588987217,0.0022124707058304226,"['PPARG', 'MEF2D']",0.9999294775799197,0,0,2
518,BDNF-TrkB Signaling WP3676,0.993167614420402,0.1905447767516733,0.0013063432044555024,['HRAS'],0.9999294775799197,0,0,1
519,Interferon type I signaling pathways WP585,0.9940391405052325,0.2629582806573957,0.0015721477088190372,"['RPS6', 'RAC1']",0.9999294775799197,0,0,2
520,Joubert Syndrome WP4656,0.9958446376412518,0.33946093276801936,0.0014135220686702901,"['TMEM17', 'CETN2', 'ARL2', 'B9D2']",0.9999294775799197,0,0,4
521,Rett syndrome causing genes WP4312,0.9961631327075899,0.24536217633562765,0.000943232798092232,"['IMPDH2', 'GABRD']",0.9999294775799197,0,0,2
522,Fragile X Syndrome  WP4549,0.9981762520110146,0.40784571553802323,0.0007444868883003297,"['EEF1A1', 'GRIP1', 'DUSP3', 'PRKAR1A', 'CDKN2A', 'AKAP5', 'GABRD', 'AP2M1']",0.9999294775799197,0,0,8
523,mRNA Processing WP411,0.9982688630187324,0.42339949148039924,0.0007335976799528801,"['SF3B5', 'SF3A1', 'NCBP2', 'CD2BP2', 'CSTF2T', 'SNRPE', 'SNU13', 'HNRNPH2', 'HNRNPAB']",0.9999294775799197,0,0,9
524,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9990711476694432,0.1346317492658956,0.00012511112795328267,['DHCR24'],0.9999294775799197,0,0,1
525,Ectoderm Differentiation WP2858,0.9995481386114962,0.3237322515212982,0.0001463151642526262,"['PLCXD3', 'ARHGDIG', 'JAKMIP1', 'CELSR2', 'MYORG', 'LY6E']",0.9999294775799197,0,0,6
526,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9995945953543252,0.11994445037923299,4.863589668214379e-05,['TKFC'],0.9999294775799197,0,0,1
527,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9997831715389771,0.30558292282430216,6.626625933603594e-05,"['GSK3A', 'THRA', 'LPL', 'PIK3C2G', 'HRAS', 'MAPK3']",0.9999294775799197,0,0,6
528,Ciliopathies WP4803,0.999860131408107,0.368531241511359,5.15495509843605e-05,"['DNAH11', 'TMEM17', 'EVC', 'ARL2BP', 'DCDC2', 'PKD1L1', 'CCDC65', 'B9D2', 'CCNQ', 'CCNO']",0.9999294775799197,0,0,10
529,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999294775799197,0.22920767716535434,1.616485009356395e-05,"['TMEM17', 'EVC', 'CDK20', 'DYNLL1']",0.9999294775799197,0,0,4
